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i 
Abstract 
Spir proteins are the primodial members of the emerging group of actin nucleation 
factors, which initiate actin polymerization by binding monomeric actin to one or multiple 
Wiskott-Aldrich Syndrome protein (WASp) homology-2 domains. Spir proteins are implicated 
in diverse cellular processes including actin dynamics, vesicle trafficking as well as 
Drosophila and mammalian oogenesis. Despite the biological roles of Spir was interpreted to 
an extent in the fields of protein and membrane interactions, the exact mechanisms by which 
the protein is regulated is still exists to be unknown. A previous study by Otto et al., (2000) 
disclosed Drosophila p150-Spir as a direct link between JNK (c-Jun N-terminal kinase) and 
actin organization, by being a downstream target of JNK function. The p150-Spir was 
phosphorylated by a constitutively active form of JNK, JNK-MKK7, both in vivo and in vitro. 
This finding came up with a new proposal for the regulatory mechanism for the Spir proteins, 
through the phosphorylation by Mitogen-activated protein kinases, eventhough a 
comprehensive phosphorylation profile was not convincingly uncovered. 
 Phosphorylation of proteins being one of the most relevant and ubiquitous post-
translational modification, it carries interest as well as importance to gain more insights into 
the influence phosphorylation on the biological activities of Spir. In analogy with the previous 
finding, the present study is directed to elucidate the phosphorylation profile of mammalian 
Spir proteins, which has not been addressed yet. Precise identification of phospho-residues 
was carried out by combining biochemical and contemporary mass spectrometry analysis. 
 Mammals exhibit two Spir proteins, Spir-1 and Spir-2. Using nano LC-MS/MS (nano-
Liquid Chromatography Tandem Mass spectrometry), the present study could localize the 
phosphorylated aminoacids in peptide sequences with three phospho-moieties reliably. 
Following the identification and characterization of phosphorylation sites, description of the 
biological events following the phosohorylation was depicted. Formin proteins are well known 
to be the prominent interaction partners of the Spir. Recently, it was identified that both 
mammalian Spir proteins interact with both mammalian Fmn subgroup proteins, formin-1 and 
formin-2 and the interaction is mediated by the KIND domain of Spir and and the Formin Spir 
Interaction (FSI) sequence at the very C-terminus of the Fmn proteins. (Pechlivanis et al., 
2009). Concomitantly, the autoregulatory interaction mediated by the N-terminal KIND 
domain and the C-terminal FYVE domain was also characterized by the phopshorylation. 
The study will generate a unique knowledge regarding the influence of post-translational 
modification on the regulatory events of Spir proteins by analysing inter and intra molecular 
interactions with the accompaniment of protein interaction studies. 
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ii 
Zusammenfassung 
Spir Proteine sind primodiale Elemente einer neuen Gruppe von Aktin-Nukleations-Faktoren, 
die Aktin Polymerisation initiieren, indem sie Aktin Monomere an ein oder mehrere Wiskott- 
Aldrich-Syndrom Protein Homologie-2 Domänen (WASp) binden. Spir Proteine werden mit 
diversen zellulären Prozessen in Verbindung gebracht, einschließlich Aktin-Dynamik, 
Vesikel-Transport und Oogenese in Drosophila und Mammalia. Obwohl die biologische Rolle 
von Spir bezüglich Protein und Membran-Interaktionen zu einem gewissen Ausmaß 
untersucht wurde, sind die genauen Mechanismen der Protein Regulation immer noch 
unbekannt. Eine vorangegangene Studie von Otto et al., (2000) deckte Drosophila p-150 
Spir als direkten Link zwischen JNK (c-Jun- N-terminale Kinase) und Aktin Organisation auf 
und identifizierte p-150 Spir als downstream target von JNK. Das p-150 Spir wurde sowohl in 
vivo als auch in vitro von einer konstitutiv aktiven Form von JNK, JNK-MKK7 phosphoryliert. 
Durch die Phosphorylierung Mitogen- aktivierter Proteinkinasen erkannte man einen neuen 
Ansatz für Mechanismen zur Regulation von Spir Proteinen, obgleich ein umfassendes 
Phosphorylierungsprofil nicht beschrieben werden konnte. Da es sich bei der 
Phosphorylierung von Proteinen um eine der wichtigsten und universellsten Formen der 
posttranslationalen Modifikation handelt, ist es sowohl von Interesse als auch von Bedeutung 
mehr Einblicke zu bekommen, wie Phosphorylierung von Spir die biologische Aktivität des 
Proteins beeinflusst. Analog zu den vorherigen Erkenntnissen hat die vorliegende Studie die 
Aufklärung des Phosphorylierungsprofils der Spir Proteine in der Klasse der zum ziel 
Mammalia. Phosphorylierungsstellen wurden mit Hilfe biochemischer und modernster 
massenspektrometrischer Methoden präzise identifiziert. Die Klasse der Mammalia weist 
zwei Spir Proteine auf, Spir- 1 und Spir-2. Die vorliegende Untersuchung konnte durch den 
Einsatz von LC-MS/MS (nano-Liquid Chromatography Tandem Mass spectrometry) die 
phosphorylierten Aminosäuren in der Peptid Sequenz mit drei Phosphorresten zuverlässig 
identifizieren. Nach Identifizierung und Charakterisierung der Phosphorylierungsstellen 
wurde eine Beschreibung der biologischen Ereignisse, welche auf einer Phosphorylierung 
beruhen, dargestellt. Formin Proteine sind bedeutende Interaktionspartner von Spir. Kürzlich 
wurde herausgefunden, dass beide Säuger-Spir- Proteine mit beiden Säuger-Fmn-
Untergruppen Proteinen, formin-1 und formin-2, interagieren und dass die Interaktion über 
die KIND Domäne von Spir und der Formin Spir Interaction (FSI) Sequenz des C- Terminus 
der Fmn Proteine erfolgt. (Pechlivanis et al., 2009) Begleitend wurde die autoregulierte 
Interaktion, die durch die N-terminale KIND Domäne und die C-terminale FYVE Domäne 
vermittelt wird, durch die Phosphorylierung charakterisiert. Die Studie wird wichtige 
Erkenntnisse über den Einfluss posttranslationaler Modifikationen von Spir Proteinen 
generieren, indem inter-und intramolekulare Interaktionen zusammen mit Protein 
Interaktionsstudien durchgeführt werden...................................................................................
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1 
1. Introduction 
 
The cellular cytoskeleton is an intricate network of filamentous proteins. The 
cytoskeleton confers upon the cells to resist deformation, to change shape during movement 
and act as a scaffolding for the attachment of many organells. Actin filaments, microtubules 
and intermediate filaments are equally involved in making up the cytoskeleton as well as 
undergo continual reorganization as a necessary requirement for cellular and morphological 
dynamics and motility. 
 
1.1.   Biology of Actin 
 Actin is a universal protein expressed in all organisms of the present day world. Since 
it´s discovery in 1942 (Bruno.F.Straub), actin has seen a long and fruitful period of 
investigations. It is manily located in the cytoplasm of the cells but is also present in nucleus 
(Dos Remedios et al., 2003). Until a short time ago, actin was  thought to have only evolved 
in eukaryotic cells.  Recently, prokaryotic proteins, like Murein formation cluster E B (MreB) 
and Partitioning M (ParM), with structural similarities to eukaryotic actin assemble into 
filaments have been discovered indicating their representment as ancestral actin 
cytoskeleton (Campellon and Welch, 2010).  
Actin filaments are major components of at least 15 distinct structures in metazoan 
cells. They get assembled in response to different stimuli into a multifarious higher-order 
cellular structures ranging from lamellipodia to microvilli, each exicuting diverse cellular 
functions. The most cited assemblies of actin include muscle sarcomeres, synapses, 
membrane protrusions like-lamellipodia/lamella, ruffles, phagocytic cups, podosomes and 
invadopodia, filopodia and microvilli, stress fibers and the contractile ring (Higgs and 
Chabbra, 2007; Welch and Mullins, 2002; Small, Rottner and Kaverina, 1999). Thus the actin 
cytoskeleton participates in many important cellular processes like muscle contraction, cell 
motility, cell division and cytokinesis, vesicle and organelle movement, cell signalling and the 
establishment and maintenance of cell junctons and cell shape.  
To perform all these functions, the constitution of actin cytoskeleton must be tightly 
regulated, which comprise the organization of actin monomers into actin polymers and 
further to filamentous network. A large repertoire of interacting partners that are still 
increasing in number, orchestrate spatial and temporal control of these phenomena which 
attribute versatile functions to actin. 
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1.2.   Actin : Structure and Dynamics 
 
1.2.1.   Actin structure 
Actin is one of the most abundant and highly conserved protein in eukaryotic cells 
that fall into three broad classes: α, β and γ-isoforms.  
Actin, the chief component of the actin cytoskeleton, exist in two forms in the cell: 
monomers (G-actin or globular actin; Figure 1A) and filaments (F-actin or filamentous actin; 
Figure 1B). 
Monomeric actin (G-actin) is composed of a single polypeptide chain of about 375 
aminoacids resulting in an approximately 43 KDa protein. The first atomic-resolution 3D 
structure of G-actin in complex with DNase I was proposed by Kabsch et al., in 1990. G-actin 
has two main domains each of which is subdivided into 4 subdomains (here they are 
represented as I -IV). N- and C- termini are both present in subdomain I. The main domains 
are seperated by a deep cleft, which occupies a tightly bound adenosine-derived nucleotide 
with a divalent cation (Mg2+ or Ca2+) (Kabsch et al., 1990). The bound nucleotide contacts 
residues from all four subdomains and functions as the coordinating center of the molecule 
(Page et al., 1998). The most favourable state for actin filament assembly is Mg-ATP-G-actin 
in the physiological state since Mg-ATP-actin nucleates about three orders of magnitude 
faster than Ca-ATP-actin (Estes et al., 1992). The actin molecule can undergo 
conformational changes according to the nucleotide and cation state or depending on the 
actin binding proteins (Schüler et al., 2001).  
Filamentous actin (F-actin) is formed by the reversible endwise polymerization of 
monomeric G-actin. The first high-resolution structural model of the actin filament at a 
resolution of 8 A° was proposed by Holmes et al., in 1990. The filaments are of 
approximately 7-10 nm in diameter. F-actin appears morphologically as either a single-start 
left-handed helix or two right-handed helices that slowly rotate each other (Chabbra. D and 
Dos Remedios, 2010). Actin filaments are polar structures with two ends that are 
differentiated by their structural and biochemical characterestics (Welch and Mullins, 2002). 
This polarity is key to the mechanism of actin assembly in cells. The fast growing end is 
called the barbed or (+) end and the slow growing end is the pointed or (-) end. The 
nomenclature of the filament is based on the arrowhead-like appearance of the F-actin when 
decorated with myosin subfragment I (S-I). These ends correspond to subdomains I and III 
and subdomains II and IV, respectively (Dos Remedios et al., 2003).  
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Figure 1. Ribbon representations of molecular structures of naturally occuring forms of actin. 
A) Crystal structure of monomeric G-actin (PDB code:1J6Z) with nucleotide binding cleft (ATP in G-
actin and ADP in F-actin) (red) and divalent cation (gold). Locations of the subdomains marked and 
numbered from I-IV (Kabsch et al., 1990). Exposed subdomains I and III, and II and IV represent 
barbed and pointed ends respectively. B) Holmes model of F-actin (Holmes et al., 1990) with 
individual actin monomers in five different colours. 
 
1.2.2.   Actin dynamics 
Actin polymerization is a classic example of self assembly and the cells regulate all 
aspects of actin assembly through a fascinating repertoire of proteins (Pollard, 2007). 
Polymerization involves three main features: 1) a slow initial association of actin monomers 
to a dimer that is more likely to rapid dissociation to monomers than association, (kinetics 
place the dissociation equilibrium constant for an actin dimer as high as 4-5 M (Welch and 
Mullins, 2002)); 2) The formation of a stable trimer that represents the nucleus of 
polymerization, a state where actin assembly is more likely than disassembly; and 3) the 
elongation phase during which actin monomers are rapidly assembled (Dos Remedios et al., 
2003) (Figure 2).  
The relative instablity of polymerization intermediates and the actin monomer binding 
proteins (ABPs), that buffer the large pool of actin monomers in the cells, supress the 
spontaneous actin polymerization. This makes nucleation as the rate limiting step in filament 
formation. Actin nucleation is the assembly of a stable F-actin like “seed“ from ATP actin 
(Winkler and Schafer, 2007). A minimum of three actin molecules need to be assembled to 
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form a polymerization-competent nucleus (Qualmann and Kessels, 2009). The factors that 
help to overcome the kinetic barrier to filament nucleation and elongation are called actin 
nucleation factors, which control the time and location of polymerization and influence the 
structures of actin networks they generate (Pollard, 2007; Chesarone and Goode, 2009; 
Dominguez and Holmes, 2010). 
 
 
Figure 2. The stages in the polymerization of monomeric G-actin to form filamentous actin. G-
actin carrying ATP will form a stable nucleus in the process, nucleation, which enable the binding of 
succeeding actin monomers and undergo elongation to give rise to filamentous, F-actin. Addition of G-
actin take place at the barbed end. As the filament ages, ATP get hydrolysed to ADP and 
depolymerization of ADP-G-actin take place at the pointed end of the filament. The released ADP is 
exchanged for ATP to take another G-actin inorder to start a new cycle of polymerization. (Adapted 
from Molecular Cell Biology, 6th Edition). 
 
An actin filament is structurally assymmetric which is reflected in a difference in rate 
of addition of G-actin at two ends- elongation at the barbed end is 10-20 times faster than 
that at the pointed end. Subunit addition at the barbed end is determined by the Critical 
concentration (Cc) of G-actin. Under physiological conditions in the cell, Cc of Mg-ATP actin 
is lower at the barbed end (0.1µM) and than at the pointed end (0.7µM) (Weber A. 1999). 
Thus polymerization take place by the preferential addition of ATP-loaded actin monomers 
primarily at the barbed end since the critical concentration of the actin monomers, is lower at 
the barbed end than at the pointed end. Hydrolysis of ATP by polymerized actin and 
dissociation of the γ-phosphate appear to be an internal timer that indicates the age of a 
filament and triggers processes that disassemble actin filaments in cells (Pollard, 2003). As 
the filament ages, ATP is hydrolyzed to ADP and inorganic phosphate (Pi) is released. ATP 
hydrolysis is irriversible and fast with a half time of about 2s and phosphate dissociation is 
much slower with a half time of 350s, so ADP-Pi-actin is relatively long-lived intermediate in 
freshly assembled filaments. The different rates of monomer association and dissociation at 
the two ends eventually developes a “steady state“ where the pointed end depolymerization 
replenishes the G-actin for the barbed end polymerization enabling the filament to perform 
“treadmilling“. The process will result in the net incorporation of ATP-actin at the (+) end 
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which equalizes the loss of ADP-actin at the (-) end. The released ADP-actin gets recharged 
with ATP for another round of polymerization (Qualmann and Kessels, 2009; Dos Remedios 
et al., 2003; Baum and kunda, 2005;  and Pollard, 2003).  
 In vivo, all steps in actin dynamics are controlled and modulated by actin-binding 
proteins. Efficient exchange of ADP for ATP is ensured by G-actin binding protein, profilin. 
Thymosin β4 control the pool of non-filamentous actin in cells by binding to actin monomers. 
Capping proteins, at the pointed end, serves protection from depolymerization and at the 
barbed end, stop actin polymerization reactions, therefore prevent excessive actin filament 
polymerization.   
1.3.   Actin nucleation machinary 
Current knowledge on the complexity of nucleation mechanisms has tremendously 
increased with a vast array of nucleators and nucleation mechanisms. They can be divided 
into three principal groups, the Arp2/3 complex and it´s large family of nucleation promoting 
factors, formins and WH2 domain - containing nucleators. Apart from the short description of 
Arp2/3 complex and formins, the rest of this thesis book gives a close-grained illustration of 
the novel class of actin nucleation factor, Spir, a WH2 domain - containing nucleator, that 
may allow a better understanding of it´s functions and localization. 
 
1.3.1.   The Arp2/3 complex 
Arp2/3 complex, the founding member of actin nucletaion factors, was first isolated 
from Acanthamoeba castellanii (Machesky et al., 1994). The 220 KDa complex is composed 
of seven stably associated polypeptides that are highly conserved in virtually all eukaryotic 
organisms (Goley and Welch, 2006). The polypeptides comprise two name giving actin-
related proteins, Arp2 and Arp3, held together by five additional Arp2/3 complex components 
(ARPC), ARPC1 (p41-Arc), ARPC2 (p34-Arc), ARPC3 (p21-Arc), ARPC4 (p20-Arc) and 
ARPC5 (p16-Arc). Metazoans, fungi, amoeba and plants express all of these subunits 
(Pollard, 2007). The crystal structure of bovine Arp2/3 complex at 2.0 A° was solved by X-ray 
crystallography giving insights to it´s organization and functions (Robinson et al., 2001).  
Among the known nucleators, Arp2/3 complex is unique in it´s ability to nucleate 
filaments as well as to organize them into branched networks. Arp2/3 complex is referred to 
as the primary nucleator of actin filaments in most crawling cells owing to their localization in 
lamellipodia and pseudopodia in the leading edge of the motile cells. The complex is also 
functionally important for actin polymerization during phagocytosis (May et al., 2000). 
The actin-related proteins Arp2 and Arp3 are postulated to mimic an actin dimer and 
serves as a nucleation site. Upon binding to an existing filament, Arp2 and Arp3 likely 
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reorient into a dimer that acts as the first two subunits of the new filament. The ARPC2–
ARPC4 heterodimer provides the main surface for interaction of the complex with the mother 
filament and anchors Arp3, the first subunit of the daughter filament (Campellone and Welch, 
2010). Arp2/3 complex has only a very moderate actin nucleation capacity on it´s own, but 
can be activated by binding to nucleation-promoting factor (NPF) proteins (Goley and Welch, 
2006). In presence of nucleation promoting factors, Arp2/3 complex catalyzes the actin 
polymerization by binding to the sides of an existing (mother) filament and initiates the 
assembly of a new (daughter) filament in a Y-branch configuration with a 70° branch angle 
(Campellon and Welch, 2010) (Figure 3). This will generate highly branched actin filaments 
that form entangled ´dendritic` networks and is central to it´s functions in vivo. Although actin 
filaments are flexible, branch junctions appear to be very rigid (Blanchoin et al.,2000). Potent 
nucleation also requires phosphorylation of Thr or Tyr residues in Arp2 (LeClaire III et al., 
2008). 
 
Figure 3. Schematic representation of Arp2/3 complex and the actin filament elicited by the 
complex.  A) Cartoonic representation of Arp2/3 complex- a seven subunit protein complex containing 
Arp2, Arp3 and five additional subunits, ARPC1-5. B) When activated by nucleation promoting factors 
(NPF) the Arp2/3 complex initiates the formation of new actin filaments from the sides of existing 
mother filaments in a Y-branch configuration with a regular branch angle of 70° (Goley and Welch, 
2006). 
 
NPFs, are classified into Class1 and Class II based on the mechanism by which they 
activate Arp2/3 complex and their effect on the Y- branching reaction (Goley and Welch, 
2006). Class 1 NPFs- bacterial protein ActA, WASP (Wiskott-Aldrich syndrome protein), 
WASP family verproline homologue (WAVE; also known as SCAR), WASP and SCAR 
homologue (WASH), WASP homologue associated with actin, membranes and microtubules 
(WHAMM) and junction-mediating regulatory protein (JMY). All proteins of WASP family 
possess a common c-terminal WCA domain with a W (WH2) domain binding to G-actin, 
amphipathic connector (C) region and an acidic (A) peptide that collectively bind Arp2/3 
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complex and thus activate the complex to polymerize branched actin filaments (Campellon 
and Welch, 2010). Class II include S.cerevisiae actin binding protein-1 (Abp1) (Goode et al., 
2001), Pan1 (Duncan et al., 2001) as well as metazoan cortactin (Weaver et al., 2001), 
possessing an F-actin binding region rather than the G-actin binding W domain in Class 1 
NPFs. NPFs are typically found associated with membranes, and they specify the front of a 
cell, ensuring that the nucleation of new filaments in a dendritic actin-filament network occurs 
only from filaments growing towards the membrane (Fletcher and Mullins, 2010). The 
activities of NPFs, in turn, are tightly regulated by the Rho-family GTPases, Cdc42 and Rac 
(Higgs and Pollard, 2000). Improper functioning of the ARP2/3 complex and its regulators 
can lead to disease like WAS, X-linked genetic disorder, caused by mutation in WASP 
encoding gene (Goley and Welch, 2006). The complex disfunction might also be associated 
with cancer metastasis (Wang et al.,2005) and might represent targets for the therapeutic 
invention. 
 
1.3.2.   Formins 
 Formins are a group of recently emerged key regulators of actin polymerization, 
which promote not only nucleation but also processive barbed-end elongation (Goode and 
Eck, 2007). Formins catalyze the formation of unbranched (linear) actin filaments involved in 
actin-based processes including polarized cables in budding yeast, contractile rings and 
interphase cables in fission yeast and stress fibers and filopodia in animal cells (Paul and 
Pollard, 2009 ; Dahlgaard et al., 2007).  
 Formins are named for the mouse limb deformity (ld) gene, the first formin gene 
identified (Zigmond, 2004). Even though much of knowledge regarding the structure and 
biochemical activity of formins were originated from the studies in yeast homologue Bni1 
(Schönichen and Geyer, 2010), nucleation activity has since been observed for vertebrates. 
Phylogenetic analysis have classified the fifteen distinct mammalian formin genes into 7 
subfamilies– Diaphanous formins (Dia 1, -2 and -3), Dishevelled-associated activator of 
morphogenesis (DAAM-1 and -2), formin-related proteins identified in leucocytes (FRL-1, -2 
and -3; also called FMNL-1, -2 and -3), `Inverted` formins (INF-1,-2), Formin homology 
domain proteins (FHOD-1,-2), Delphilin and formin sub family of Formins (Fmn-1 and Fmn-2) 
(Higgs and Peterson, 2005; Goode and Eck, 2007). 
 Formins are large multidomain proteins of > 1000 aminoacid residues that are 
composed of various combinations of different functional domains. Formins are defined by a 
unique and highly conserved C-terminal formin homology 2 (FH2) domain usually flanked by 
formin homology 1 (FH1) domain, N-terminal to FH2 domain (Figure 4) (Faix and Grosse, 
2006). The N-terminal part is very divergent within the formin protein family. 
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 FH2 domain typically ~ 400–500 amino acids long, is necessary and sufficient for 
actin nucleation. The domain mediates actin binding, actin nucleation and processive 
capping. The FH2 domains form homodimers, which assume a ring-like structure that 
encircles the elongating actin filament at its fast-growing end, promoting its elongation and 
protecting it from other capping proteins. Thus FH2 domain appears to be a processive cap 
that walks with the barbed end of the filament as it elongates. FH2 domains are active as 
dimers (Moseley et al, 2004) and mutations that disrupt the dimerization abolish actin 
polymerization activity (Xu et al, 2004).  
 
Figure 4.  Domain array of mammalian formin proteins, Fmn-1, Fmn-2 and mDia1. Mammalian 
formin-1 (mm formin-1), mammalian formin-2 (mm formin-2) proteins correspond to Swiss-Prot entry 
numbers Q05860 and Q9JL04 are shown. Proline rich FH1 domain is succeeded by actin binding FH2 
domain. FH1 domain of Fmn-2 has extensively repeated proline motifs. At the very C- terminus a 
conserved sequence motif, FSI is depicted, which is unique for Fmn subfamily of formins. Several 
members of the formin superfamily contain an autoregulatory peptide (DAD) in their C-termini at the 
position where the FSI sequence is located. In Diaphanous family formins (the structure of mDia1 
protein is shown) the intramolecular interaction between the C-terminal DAD domain and a N-terminal 
DID results in an autoinhibited conformation of the formin proteins. Abbreviations: FH1, Formin 
homology 1 ; FH2, Formin homology 2; FSI, Formin Spir Interaction sequence; GBD, GTPase binding 
domain; DID, Diaphanous inhibitory domain; DD, Dimerization domain; DAD, Diphanous 
autoregulatory domain. 
 
The FH1 domain is a proline-rich region that binds to profilin–actin complexes and 
enhances the delivery of new actin monomers onto the growing filaments (Paul and Pollard, 
2008). Two principal roles of the FH1 domain is appeared to be, 1) the FH1 domain is 
required for formins to efficiently use profilin-bound actin to build filaments; 2) FH1-profilin 
interactions increase the rate of filament elongation. In short, FH2 domain is sufficient in 
catalyzing the filament nucleation where as FH1 domain in stimulating filament elongation. 
Mammalian Fmn subgroup of formins possess a FSI (Formin Spir Interaction) 
sequence at the very C-terminus of the protein which mediate the interaction with the KIND 
domain of mammalian Spir proteins (Figure 4) (Pechlivanis et al., 2009). 
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Formins govern two distinct phases of actin assembly: nucleation and elongation 
(Figure 5). The mechanism of actin assembly primarily involves the high affinity binding of 
their dimeric donut-shaped FH2 domains to the barbed ends of actin filaments. Since FH2 
domain lacks detectable affinity for actin monomers, it has been hyothesised that they 
catalyze polymerization by binding and stabilizing spontaneously formed actin dimers or 
trimers and thus defeating the kinetic hurdle (Pring et al., 2003). These interactions depend 
on the ability of FH2 domains to dimerize. Each functional half of the FH2 dimer is called a 
`hemi-dimer`or bridge and contains two F-actin-binding sites (Ottomo et al., 2005). During 
the filament elongation FH2 dimer exists in alternating morphologies at the barbed end – 
`open` and `closed` structural states. In closed conformation, both FH2 monomers bind the 
two terminal actin subunits at the filament end, blocking further actin incorporation. In open 
conformation, actin incorporation is enabled and the barbed end can assoiate with a new 
actin subunit (Campellone and Welch, 2010). Once a filament is nucleated, the dimeric FH2 
domain moves processively with the growing barbed end, shielding it from capping proteins 
terminating the elongation, while permitting the rapid addition of new subunits.  
 
Figure 5. Actin nucleation by formins. Formins are large multidomain proteins that initiate the 
polymerization of unbranched actin filaments. The formin homology-2 (FH2) domain initiates filament 
assembly and remains  associated with the fast-growing barbed end, enabling further addition of actin 
subunits while protecting the end from capping proteins. Proline rich formin homology-1 (FH1) domain, 
recruits profilin–G-actin complexes to the barbed ends of the growing filament (Pieta K. Mattila & 
Pekka Lappalainen, 2008).   
 
Following nucleation, the adjecant Pro-rich FH1 domain comes in action for the 
subsequent elongation of the filament. Profilin is a ubiquitous actin monomer binding protein 
with separate binding sites for monomeric actin and polyproline tracts. Therefore, the 
interaction between profilin and the FH1 domain are crucial for the recruitment of new ATP-
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G-actin residues from profilin-actin complexes to the FH2 domain for incorporation into the 
growing filaments at their barbed ends (Chesarone, DuPage and Goode, 2010; Faix and 
Grosse, 2006). FH1-FH2 dependent acceleration of barbed end elongation is as much as 5-
fold over the rate of elongation at the free barbed ends (Kovar et al., 2006). 
Regulation of formins appears significantly different for every formin family 
(Schönichen and Geyer, 2010). Many formins `rest` in an autoinhibited state in the cytosol 
and must be activated by specific ligands. Rho family GTPases are known to play an 
important role in activating both mammalian and yeast systems (Heasman and Ridely, 2008). 
The best understood mechanism of regulation is the autoinhibitory interaction which 
was well studied in Diaphanous-related formins (DRFs), a conserved subfamily of formins 
and known to be the direct effectors of Rho-family GTPases as well. The DRFs include the 
Dia, DAAM and FRL formins in mammals and Bni1, Bnr1 and SepA in yeast (Goode and 
Eck, 2007).  Formin autoinhibition is mediated by interactions between the N- and C-terminal 
functional halves. The actin assembly apparatus in the C-termini encompass FH1-FH2 
module and the Diaphanous auto-regulatory domain (DAD). The N-termini is the regulatory 
region which include GTPase binding domain (GBD), which binds to Rho family GTPases, 
Diaphanous inhibitory domain (DID), that participate in autoinhibition, the dimerization 
domain (DD) and a coiled-coil region (Li and Higgs, 2003; Ottomo et al., 2005). The binding 
of DAD to the GBD-DID is obstructing the actin polymerizing activity of FH2 domain (Wallar 
et al., 2006). This inhibitory interaction is disrupted by the binding of RhoA to the GBD-DID 
resulting in the activation of FH2 (Lammers et al., 2005). For other metazoan formins, auto-
inhibitory sequences are less clear. Formins of FHOD group possess DAD regions but not 
DID and that of FMN, INF and Delphilin groups contain neither DID or DAD (Higgs H N, 
2005). The differences in the diversity of domains attributed to regulatory mechanisms 
underscores the importance of their structural analysis. 
 
1.3.2.1.   Formin-2 
The Fmn-2 genes in mouse and humans share conservation of sequence and 
genomic location, and are expressed throughout the brain and spinal cord (Leader B and 
Leder P, 2000). Human and mouse formin-2 share 90% identity over the C-terminus  and 
79% identity over most of the N-terminus. Also, human formin-2 showed 74.7% total-amino-
acid identity with mouse Fmn2, and 31.9% total-amino-acid identity with human formin-1 
(Katoh and Katoh, 2004). Formin-2 is also similar to Drosophila Cappuccino with 37% 
identity in the C-terminus. The high similarity among formin-1, formin-2 and Cappuccino bring 
them all together in the Fmn group of formins. Formin-2 contains both the FH1 and the FH2 
domains. The FH1 domain of formin-2 possess the most extensively repeated proline motif 
yet described in the family (Leader and Leder, 2000). Recently, a new conserved sequence 
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motif namely FSI (Formin Spir Interaction sequence) have been identified in the very C-
terminus of formin-2 protein adjecant to FH2 which is unique among the members of Fmn 
subgroup of formins from flies, fish, birds and mammals. The FSI region of both mammalian 
formin (formin-1/2) proteins is mediating the interaction with KIND domain of both 
mammalian Spir (Spir-1/2) (Figure 4). (Pechlivanis et al., 2009). 
Formin-2 is preferentially expressed in developing Central Nervous System (CNS) 
during embryogenesis. The expression begins in the developing spinal cord and brain 
structures and continues in neonatal and adult brain structures including the olfactory bulb, 
cortex, thalamus, hypothalamus, hippocampus and cerebellum. The similar expression 
pattern of mouse and human formin-2 in the developing and mature CNS suggests a similar 
role for the human and mouse genes. It also shares similar expression pattern with a distinct 
actin nucleation factor, Spir-1 which has predominant expression in brain. Both genes were 
found to be expressed in the developing nervous system. The expression of both the genes 
was again identical in the adult brain, with the highest expression in CA1, CA2 and CA3 
fields in the hippocampus, garanular layer of dentate gyrus and in the Purkinje cells in 
cerebellum. The strong overlapping expression patterns of two distinct classes of actin 
nucleators, Spir-1 and Formin-2, suggests a strong functional correlation between the two 
(Schumacher et al, 2004). Even though formin-2 is predominantly expressed in the nervous 
system, the corresponding deficient mice have no abnormalities in the nervous system. Fmn-
2 deficient mice exhibit hypofertility due to a failure in correct metaphase spindle positioning 
during meiosis I. In 2002, Leader B et al. showed that Fmn2 is expressed in the developing 
mammalian oocyte and required for DNA-spindle positioning during meiosis I. Later, Schuh 
and Ellenberg (2008) showed in live mouse oocytes that spindle relocation, which is 
essential for fertility, requires a continuosly reorganizing cytoplasmic actin network nucleated 
by Fmn-2.  
 
1.3.3.   WH2 domain-containing nucleators 
Following the buzz of Arp2/3 complex and formin family into the world of actin 
polymerization, a new genere of nucleating proteins were launched that contain one or 
multiple actin binding WH2 motifs, as their signature. They include Spir (4 WH2) (Quinlan et 
al., 2005), Cordon-Bleu (Cobl) (3 WH2) (Ahuja et al., 2007), Leiomodin (Lmod) (1 WH2) 
(Chereau et al., 2008) as well as bacterial nucleators– VopF/VopL (3 WH2) (Liverman et al., 
2007) and TARP (1 WH2) (Jewett et al., 2006). Even though the WH2 domain is shared by 
NPFs of ARP2/3 complex, WASP, and the amino-terminal portion of Thymosin β4 (Paunola 
et al., 2002), neither can trigger the actin nucleation on its own and this feature put Spir 
proteins in the world of it´s own as a versatile actin nucleation factor. 
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Spir Proteins 
Spir proteins are the primodial member of the emerging group of actin nucleation 
factors with tandem cluster of WH2 domains. In 2005, Quinlan et al. revealed a fillip to give a 
new lease on actin nucleation machinary catalyzed by Spir proteins which were about to 
complete the trio of factors, along with Arp2/3 complex and Formins.  
Spir gene was first identified in Drosophila together with Capuccino, Drosophila 
formin, in a Drosophila screen to elucidate their requirement for proper development of 
oocytes and embryos. Mutations in either gene resulted in the failure of the egg, and later the 
developing embryo, in establishing the polarity (Manseau and Schüpbach, 1989). Since then 
Spir proteins have been exclusively identified in metazoans.  
Vertebrate genome encode two spir genes, Spir-1 and spir-2 (Schumacher et al., 
2004) and the corresponding proteins Spir-1 and Spir-2 have a high similarity. Spir-1 
expression was identified in developing nervous system as well as in adult brain. In the adult 
brain, high expression was found in the Purkinje cells of cerebellum, neuronal cells of 
hippocampus and dentate gyrus. In addition to the nervous system, Spir-1 was also detected 
in fetal liver and adult spleen (Schumacher et al., 2004). Spir-2 gene possess broader 
expression pattern when compared to Spir-1 gene, which was detected throughout the 
digestive tract, brain, testis and kidney with no significant expression in spleen, lung and liver 
(Pleiser et al., 2010). Until now, the class of Spir proteins comprises – Drosophila Spir 
(dSpir), vertebrate Spir-1 and Spir-2, the sea squirt Ciona Savignyi PEM-5 (posterior end 
mark-5) (Wellington et al., 1999) and pEg6 of the African clawed frog Xenopus (Le Goff et 
al., 2006). 
Spir has a unique mechanism in actin nucleation and polymerization, sharing only 
limited functional hallmarks with the Arp2/3 complex and formins. Similar to formins but 
unlike Arp2/3 complex Spir induce unbranched, linear actin filaments (Quinlan et al., 2005). 
Spir resembles Arp2/3 complex in that it remains bound to the pointed end of newly formed 
actin filaments whereas formins processively move along with the barbed ends of the actin 
strutures. But, a recent study put direct evidence in front showing that Spir binds to the 
barbed end of the actin filament, under conditions where Spir accelerates actin 
polymerization (Takuto et al., 2011). Otherwise Spir has no sequence homology to the formin 
family of proteins or to the subunits of Arp2/3 complex (Quinlan et al., 2005). 
 Spir proteins form a well-conserved family in animals. They are single polypeptides 
with multiple domains starting from the N-terminus to C-terminus: KIND, a cluster of four 
WH2 domains, Spir box and FYVE domain (Figure 6).   
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Figure 6. Domain architecture of Spir proteins: All known Spir proteins share a common structural 
array with an N-terminal Kinase non-catalytic C-lobe domain (KIND) followed by a cluster of four 
WASP homology-2 (WH2) domains in the center. The C-terminus comprises Spir Box and modified 
FYVE-Zn-finger domain.    
 
KIND (Kinase non-catalytic C-lobe domain) was first identified by Ciccarelli et al., 
as a conserved region in the N-terminal half of Spir proteins and named the region based on 
its sequence similarity to the C-lobe of the protein kinase fold (Ciccarelli et al., 2003). The 
KIND domain is found only in metazoa. The region significantly matched various catalytic 
domains of protein kinases but the best similarity was found to p21-activated kinase (PAK), a 
serine threonine phosphotransferase (Ciccarelli et al., 2003). Multiple sequence analysis of 
different protein kinases defined a characterestic eukaryotic protein kinase catalytic domain, 
`a kinase fold`, with about ∼ 200-350 amino acids, with 11 major conserved motifs (Hanks 
and Quinn, 1991). The fold harbours two structurally independent subdomains connected by 
a short linker region: a short N lobe formed by a β sheet and an α helix that contributes to the 
binding of ATP, and a larger and mainly helical C-lobe that contains the catalytic residues 
and the activation loop. Spir protein has the entire C-lobe of the kinase domain without the 
essential catalytic residues required for the kinase activity, which names the novel region as 
Kinase non-catalytic C-lobe domain. Also Spir proteins are devoid of the N-lobe as well as 
the linker region of the kinase domain (Ciccarelli et al., 2003). But the KIND domain evolved 
from a functional kinase turned into an interaction module since the substrates of the protein 
kinases interacts with the α helical regions in the C-lobe. This fact was initially characterized 
by the discovery of the specific interaction between the Spir-KIND domain and Fmn 
subgroup of Formin superfamily, prominent interaction partners of Spir (Quinlan et al., 2007). 
The first atomic structure of KIND domain was revealed recently (Zeth K et al., 2011). The 
crystal structure of KIND domain was determined at 2.05 A° and showed an almost complete 
α-helical fold with a small three-stranded β-sheet (Zeth K. et al., 2011). 
The central region of Spir proteins encodes a cluster of four WH2 repeats- the name 
derived from the WASP (Wiskott-Aldrich syndrome protein) homology domain 2. They 
comprise 17-27 amino acid long actin binding motifs. The actin nucleation activity of Spir 
proteins resides in the WH2 domains (Figure 7). These WH2 domains, designated A, B, C, 
and D (from N- to C-terminal) connected together through intervening sequences, linker 1 
through to linker 3 (L-1, L-2, L-3) (Quinlan et al., 2005). The sequence allignments revealed 
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that the four WH2 domains, especially WH2-B and WH2-D (Wellington et al., 1999), and the 
linker regions are conserved in Spir proteins belonging to different species (Kerkhoff, 2006). 
The C-terminal half of the WH2 cluster with WH2-C, L-3 and WH2-D, are crucial for 
nucleating actin assembly (Quinlan et al., 2005). A stabilized actin dimer is formed by the 
close coordinated activity of WH2-C and WH2-D through L-3, in that each taking an actin 
monomer. Afterwards, WH2-B and WH2-A add the third and fourth monomer to the initial 
dimer. Mutational studies indicate that among the four WH2 domains of Spir, the C and D 
domains have the strongest nucleation potential and removal of the C-D fragment and the 
replacement of L-3 nearly abolish the nucleation activity (Quinlan et al., 2005).  
 
 
Figure 7. Mechanism of actin nucleation by Spir proteins: A) The tandem WH2 domains are 
designated as A, B, C and D, and the coresponding linker regions as L-1, L-2 and L-3. First two actin 
monomers get bound to WH2-D and WH2-C to initiate the formation of an actin dimer and are 
stabilized by L-3. Subsequently G-actin is added to WH2-B and WH2-A to form trimers and tetramers. 
B) Four actin monomers are bound to the cluster of four WH2 domains. C) Further polymerization 
occurs at the barbed end whereas Spir proteins remain bound to the ponted end of the actin filament, 
(Kerkhoff, 2006). 
 
Spir localization at the intracellular membrane structures is attributed to the integrity 
of the C-terminal half of the protein encompassing- modified FYVE zinc finger domain and 
Spir box (SB) located N-terminal to the FYVE domain.  
Spir box (SB) is a highly conserved region among Spir family proteins sharing 
sequence homology to α-helical domain of rabphilin-3A, also located adjacent to its FYVE 
finger-related zinc finger motif  (Ostermeier and Brunger, 1999). The rabphilin-3A α helix N-
terminal to its FYVE-related zinc-finger motif mediates the interaction with GTP loaded 
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Rab3A and Rab3A GTPase. The homology of the Spir-box and the rabphilin-3A α helix 
suggested a role for the Spir-box in mediating the association of the Spir actin organizers 
with Rab GTPase (Kerkhoff et al., 2001). Spir proteins colocalize with Rab11 GTPase, at the 
trans-Golgi network, post-Golgi vesicles and the recycling endosomes. Still, a direct 
interaction of Spir with Rab GTPase has not been shown yet. 
The modified FYVE zinc finger domain (mFYVE) is named after the four cysteine-
rich proteins: Fab 1 (yeast orthologue of PIKFYVE), YOTB, Vac 1 (vesicle transport protein), 
and EEA1 (Early Endosomal Antigen 1), in which it has been found. FYVE domains are 
membrane binding modules. The FYVE finger has eight potential zinc coordinating cysteines. 
The structure forms a `turret loop` which helps in penetrating the membrane (Hurley, 2006). 
A hallmark of FYVE domains is the cluster of basic amino acids between cysteines 2 and 3 
of the consensus sequence, mediating the interaction with phosphatidylinositol 3-phosphate 
(Stenmark, 2005). The Spir zinc finger motif is a modified version of the FYVE domains 
(mFYVE), lacking the basic cluster between cysteines 2 and 3 and having a loop insertion 
between cysteines 6 and 7. The Spir actin organizers are targeted to intracellular 
mambranes by their modified FYVE zinc finger domain and is involved in vesicle transport 
processes (Kerkhoff, 2001 and Morel et al., 2009). 
  
WH2- domain containing actin nucleators other than Spir include: 
Cobl, has three WH2 domains for actin binding and promote nonbundled, 
unbranched actin filaments. It seems to be a vertebrate-specific nucleator (Qualmann and 
Kesels, 2009) with restricted expression in brain (Ahuja et al., 2007). Even if the cellular 
functions of Cobl are just beginning to be explored, it has been found out that in neurones 
Cobl is crucial for neuritogenesis and dendritic branching (Ahuja et al., 2007). 
Lmod is a muscle specific actin nucleation factor (Chereau et al., 2008), with 
isoforms, Lmod-1 expressed in smooth muscles, Lmod-2, latest actin nucleator to be 
characterized, expressed in cardiac muscles and the uncharacterized Lmod-3, fetal 
leiomodin (Conley et al., 2001). The domain organization of Lmods has resemblence to 
tropomodulins (Tmods), proteins that cap actin filament pointed ends (Chereau et al., 2008). 
Unlike Cobl, Lmod has only one WH2 motif in the C-terminus and elicites unbranched actin 
filaments. The Lmod is localized to the middle of muscle sarcomeres and the knock down of 
the protein severely affects the sarcomere assembly in cultured muscle cells. 
Recently two remarkable bacterial actin nucleators have been found out- VopF in 
Vibrio cholerae and VopL in Vibrio parahaemolyticus, each with three WH2 domains for 
accelerating the actin polymerization and both nucleate the actin filaments that grow from the 
barbed end (Tam et al., 2007). TARP (translocated actin recruiting phosphoprotein) from 
Chlamydia trachomatis also contains one WH2 domain (Jewett et al., 2006). These 
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observations suggest that pathogens adopted Spir-like actin nucleation mechanism to 
manipulate host cytoskeleton.  
 
1.4.   Synergy amongst two distinct nucleators, Spir and formin  
 Formins are the known prominent interaction partners of Spir (Quinlan et al., 2007; 
Pechlivanis et al., 2009). Cappuccino (Capu; in Drosophila) and formin-1 and formin-2 (Fmn-
1 and fmn-2 in mammals) belong to the formin (Fmn) subgroup of formins. Like formins, 
mammals have two homologous Spir proteins, Spir-1 and Spir-2. Progressive studies to 
elucidate the interaction between Spir and formin was revealed by the finding that the actin 
nucleation factors, Spire and Capu, are required to construct as well as to maintain the 
polarity in developing Drosophila oocytes using both actin and microtubule systems 
(Theurkauf et al., 1992). Both proteins cooperate in the generation of a dynamic actin mesh 
in the oocyte that prevents premature ooplasmic streaming and loss of either have an 
identical phenotype in early Drosophila oogenesis (Dahlgaard et al., 2007), inducing 
premature cytoplasmic streaming, loss of oocyte polarity, and female sterility (Theurkauf et 
al., 1992; Emmons et al., 1995; Wellington et al., 1999). Analogous to Drosophila 
counterparts, Spire and Cappu, mammalian formin-2 and spir-1 genes are coexpressed in 
the developing and adult nervous system, and the corresponding proteins interact each other 
(Schumacher et al., 2004; Quinlan et al., 2007; Pechlivanis et al., 2009). Recently it was 
found that a dynamic actin mesh, as during Drosophila oogenesis, is also required for mouse 
oogenesis. The correct localization of the meiotic spindle during mouse oogenesis and the 
resulting asymmetric division depends on an actin mesh that is built up by formin-2. Myosin-2 
generates the pulling forces required for spindle movement (Schuh and Ellenberg, 2008). 
 Quinlan et al. (2007) observed the interaction between Spir and Capu both in vivo 
and in vitro which showed that the Spir-KIND/Capu-FH2 has more affinity in interaction at a 
stoichiometry of 2:2 (two KIND monomers to one FH2 dimer) when compared to that in 
between Spir-WH2/Capu-FH2. Subsequently the interaction inhibits actin nucleation by Capu 
but enhances that by Spir (Quinlan et al., 2007). The interaction was also studied with 
mammalian isoforms, Spir-1 and formin-2. The KIND-FH2 interaction is evolutionarily 
conserved. Further anatomization of this interaction by Pechlivanis et al., (2009) revealed 
high affinity Spir binding site at the very C-terminus of formin-2, designated as Formin Spir 
Interaction (FSI) sequence adjacent to its core FH2 domain. The FSI sequence was found to 
be highly conserved within the Fmn subfamily of formin proteins and absent in other formin 
subfamilies. Both mamalian Spir proteins Spir-1/2 interact with both mammalian formin 
proteins Fmn-1/2 and FSI interacts with the KIND domains of both Spir-1 and Spir-2 with a 
similar affinity (Pechlivanis et al., 2009). 
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1.5.   Spir- regulation 
 The regulation of Spir proteins can be proposed on the basis of protein interaction 
and protein phosphorylation even though a better understanding is necessary. An approach 
towards the regulation of Spir was proposed on the basis of the phosphorylation of 
Drosophila p150-Spir proteins by the mitogen-activated protein kinase (MAPK), JNK (c-Jun 
N-erminal kinase) (Otto et al., 2000). MAPKs are specific serine/threonine kinases which 
respond to various stimuli and control a variety of cellular activities including gene 
expression, mitosis, cell differentiation and cell survival/apoptosis. Signal transduction occurs 
by a series of three kinases that form a phosphorylation relay. The activated MAPKKK, by 
the phopshorylation of Ser and Thr residues, phosphorylates MAPK-kinase (MAPKK), which 
then becomes active and phosphorylates the MAP kinase (MAPK). MAPKK is a “dual 
specific“ enzyme, phosphorylates Thr-X-Tyr motif located in the kinase activation loop (Davis 
R J, 2000). Studies of a large number of MAPKs demonstrate that this mechanism of 
activation is conserved in many organisms, including plants, yeast, nematodes, insects, and 
mammals (Cathy Tournier et al., 2001). This phosphorylation enables the MAPK to 
translocate to nucleus and phosphorylate their target protein(s) (Cavigelli et al., 1995). Three 
best characterised subfamilies in vertebrates are named, extracellular-signal regulated 
kinase (ERK), c-Jun N-terminal kinase (JNK) and p38. Two different MAP kinases, MKK4 
and MKK7, are implicated in the activation of JNK group of kinases (Wang et al., 2006). 
Although both MKK4 and MKK7 are dual-specificity protein kinases that can phosphorylate 
JNK on Tyr and Thr, in vitro experiments indicate that these sites are phosphorylated 
selectively by MKK4 and MKK7, respectively (Cathy Tournier et al., 2001). And of these two, 
MKK7 selectively activates only JNK (Jacobs et al., 1999 and Cathy Tournier et al., 2001). 
 C-terminal region of p150-Spir with a smallest fragment comprising 53 amino acids at 
the DEJL motif (docking site for Erk and JNK containing LXL motif), which is not highly 
conserved within the Spir-family proteins, mediates the interaction between Drosophila p150-
Spir and JNK (Otto et al., 2000). Colocalization studies in NIH 3T3 cells transiently 
transfected with both p150-Spir and JNK, revealed that JNK translocated to and colocalizes 
with p150-Spir at discrete spots around the nucleus. Moreover, C-terminal sequences of 
p150-Spir were shown to get phosphorylated both in vitro and in vivo by JNK-MKK7, a 
constitutively active JNK. Since Erk and JNK MAP kinases are recruited to substrate proteins 
via docking sites, enabling the kinases to phosphorylate serine or threonine residues 
adjacent to prolines (S/TP motifs) (Jacobs D et al., 1999) and as p150-Spir contains a JNK 
docking site (the DEJL motif) with several potential S/TP phosphorylation motifs, 
electrophoretic mobility shift exhibited by p150-Spir supports the fact that p150-Spir is a 
phosphorylation target of JNK. Colocalization of p150-Spir with F-actin and induction of 
clustering of F-actin around the nucleus following the co-expression with p150-Spir, observed 
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in mouse fibroblasts led to the conclusion that besides being a downstream target of JNK 
function, p150-Spir also provides a direct link between JNK and actin organization (Otto et 
al., 2000). In analogy to the p150-Spir, this part of the study points on the post-translational 
modification (phosphorylation) of mammalian Spir proteins. 
1.6.   An overview on Post-translational modifications and Mass spectrometry 
1.6.1.   Post-translational modifications (PTMs) 
The term post-translational modification refers to the addition or removal of a 
functional group from an aminoacid, resulting in reversible modification of the protein activity. 
PTMs of a protein can determine its activity state, localization, turnover, and interactions with 
other proteins (Mann and Jensen, 2003). About 300 types of post-translational modifications 
of proteins are known to occur physiologically (Jensen, 2004). However, only some of them 
have been reported to play crucial roles in protein function in general.  
Of all known post-translational protein modifications, protein phosphorylation has 
turned out to be one of the most biologically relevant and ubiquitous PTM, since the isolation 
of phosphoserine (first described as serine phosphoric acid) in 1932 by Phoebus A.Levene 
and Fritz A.Lipmann (Pradela and Albar, 2007). It is estimated that one-third of eukaryotic 
proteins are phosphorylated as a result of carefully regulated protein kinase and protein 
phosphatase activities, which differ in their kinetic properties, substrate specificities and 
cellular or tissue distribution. Phosphorylation and dephosphorylation catalyzed by these 
counteracting enzymes can modify the function of a protein. Thus protein phosphorylation 
has been shown to be the key regulator in cell division, signal transduction etc. The 
simplicity, flexibility and reversibility of phosphorylation, coupled with the ready availability of 
ATP as a phosphoryl donor, explain its selection as the most general regulatory device 
adopted by eukaryotic cells (Cohen P, 2002). Among the aminoacids that can be 
phosphorylated, O-phosphates are the most common class and are mostly attached to 
serine (Ser), threonine (Thr) and tyrosine (Tyr) residues. The occurence of phosphorylation 
on Ser and Thr residues is more frequent than on Tyr residues, with the ratio of 
pSer/pThr/pTyr in the order of 1800:200:1 (Reinders and Sickmann, 2005; Witze et al., 
2007). Protein phosphorylation events are detected by increase in aminoacid residue mass 
of +80Da, which report the addition of HPO3 (Witze et al, 2007).  
 Despite its relevance, the analysis of protein phosphorylation has been revealed as 
one of the most challenging tasks due to its highly dynamic nature and low stoichiometry. A 
comprehensive study of protein phosphorylation should include the identification of 
phosphoproteins and sites of phosphorylation, identification of proteins involved in the 
process (kinases and phosphatases) and description of the biological events following the 
phosphorylation (Pradela and Albar, 2008).    
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Identification of sites of post-translational modification is crucial for elucidating the 
biological roles of any given protein. Low stoichiometry of many PTMs makes 
characterization of the sites of modification challenging. Several approaches can be 
employed for the identification of PTMs of proteins like Mass spectrometry, 2D gel analysis, 
sequencing by Edman´s degradation and computational prediction (Johnson and Eyers, 
2010; Hjerrild and Gammeltoft, 2006). Due to it´s sensitivity and specificity, Mass 
spectrometry (MS) has become a powerful analytical strategy in proteomics and a method of 
choice for unbiased analysis of protein phosphorylation. 
 
1.6.2.   Mass spectrometry  
A mass spectrometer produces ions from the substance under investigation, 
seperates them according to their mass-to-charge ratio (m/z), and records the relative 
abundance of each ionic species present. MS measurements are carried out in gas phase. 
A Mass spectrometer can be divided into three fundemental parts, 
• Ionisation source 
• (m/z) analyzer and  
• Detector 
  Individual components of a mass spectrometer are shown in Figure 8. MS analysis of 
the sample can be performed in two ways: bottom-up and top-down. In the bottom-up 
approach, proteins are enzymatically digested into peptides prior to MS analysis, whereas in 
a top-down method an intact protein is analyzed. Of these bottom-up approach is the most 
popular one for the protein identification by peptide sequencing. In this approach, digestion of 
protein is carried out by proteolytic enzymes (usually Trypsin) to obtain peptide mixtures 
which are further fractionated by reversed-phase liquid chromatography (RP-LC) followed by 
mass spectrometry. The obtained peptides are fragmented preferentially via collision induced 
dissociation and the corresponding tandem mass spectra are collected. The peptide 
sequence information from the resulting fragment ions are then searched in a database using 
appropriate algorithms. 
 The mass spectrometer used for the study is Tandem Mass Spectrometer (Tandem 
MS or MS/MS) namely QTOF-mass spectrometer (QStar XL, Applied Biosystems GmbH, 
Darmstadt, Germany) directly coupled to nano-HPLC system (Agilent Technologies GmbH, 
Boeblingen, Germany). A tandem MS is used to determine structural features of a compound 
(here protein) comprising the aminoacid sequence, site of attachment and the type of PTM. 
In this case, detailed structural features of the peptides can be obtained from the analysis of 
the masses of the resulting fragmented ions inside the mass spectrometer. 
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Figure 8 . Components of a Mass spectrometer. 
        
Outline of the working of Mass spectrometer. 
 
1. Sample introduction 
The method of sample introduction to the ionisation source often depends on the ionisation 
method being used, as well as the type and complexity of the sample.  
 The sample can be inserted directly into the ionisation source, or can undergo some 
type of chromatography en route to the ionisation source. This latter method of sample 
introduction usually involves the mass spectrometer being coupled directly to a high pressure 
liquid chromatography (HPLC), gas chromatography (GC) or capillary electrophoresis (CE) 
separation column, and hence the sample is separated into a series of components which 
then enter the mass spectrometer sequentially for individual analysis. The current study uses 
reversed phase liquid chromatography (RP-LC). The outlet of a RP column can be directly 
coupled to the inlet of the MS to analyze complex peptide mixtures, a method known as LC–
MS. In a typical LC–MS experiment, the peptides are eluted from a RP column according to 
their hydrophobicity, are ionized via ESI and, then, transferred with high efficiency into the 
MS for analysis. 
 
2. Ionization 
 For analyzing biomolecules by MS, the ability to transfer large and polar analytes of 
interest into gas-phase ions are taken in credit. The development of soft ionization methods 
like, MALDI and ESI, have enabled the transfer of polar, nonvolatile, and thermally unstable 
proteins and peptides into the gas phase without extensive degradation. The study employs 
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ESI, a technique used to produce gas-phase ions from the analyte in solution. During ESI, 
the analyte is dissolved in volatile solvent and is passed through a high voltage needle at 
atmospheric pressure over which a voltage of 3-5 kV is applied. As a consequence of this 
strong electric field, the sample emerging from the tip of the needle is dispersed into aerosol 
of tiny charged droplets assisted by nebulising gas. Solvent from the droplet is evaporated 
and the droplet gets smaller. The process of repeated evaporation ultimately release multiply 
charged individual gas phase analyte ions and make their way to the analyzer of the MS. 
 
3. Mass analyzers 
 Mass analyzers are an integral part of each instrument because they can store ions 
and separate the ions formed in the ionisation source of the mass spectrometer according to 
their m/z ratios. Among the numerous mass analyzers, the better known of which include:  
• Time-of-flight (TOF) mass analyzers 
• Quadrupole (Q) mass analyzers 
• Ion trap (Quadrupole ion trap, QIT; linear ion trap, LIT or LTQ) mass analyzers 
• Fourier-transform ion cyclotron resonance (FTICR) mass analyzers 
• Orbitrap mass analyzers 
Mass analyzers mainly differ in how they determine the m/z ratios of the peptides. 
The tandem MS employed in this study uses Quadrapole-Time-of-flight geometry 
(QTOF). Since the analysers are of two different types, the respective MS is a hybrid one. 
The two analyzers are seperated by a collision cell into which an inert gas is admitted to 
collide with the selected sample ions and bring about their fragmentation. 
3.1. Fragmentation methods  (Peptide sequencing by tandem mass spectrometry) 
 Within an MS, individual proteins or peptides are separated and fragmented for 
sequencing and for the localization of post-translational modification site(s). The fragment 
mass data can then be used to search the database for peptide identification. 
Collision-induced dissociation (CID), also called collision-activated dissociation 
(CAD), is the most common peptide fragmentation method. There are three different types of 
bonds that can fragment along the amino acid backbone: the NH-CH, CH-CO, and CO-NH 
bonds. Each bond breakage gives rise to two species, one neutral and the other one 
charged, and only the charged species is monitored by the mass spectrometer. The charge 
can stay on either of the two fragments depending on the chemistry and relative proton 
affinity of the two species. Figure 9 shows a peptide with four aminoacids having six possible 
fragment ions for each amino acid residue and are labelled with the a, b, and c ions having 
the charge retained on the N-terminal fragment, and the x, y, and z ions having the charge 
retained on the C-terminal fragment. The most common cleavage sites are at the CO-NH 
bonds which give rise to the b and/or the y ions. The mass difference between two adjacent 
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b ions, or y ions, is indicative of a particular amino acid residue. 
 
 
Figure 9. Fragmentation of a peptide containing four aminoacids. The cleavage can happen at 
different positions. If the charge remains on the N terminal fragment, the ion is named as either a, b or 
c. If the charge remains on the C terminal fragment, the ion type is either x, y, or z. The cleavage of 
the peptide bond is very common for a CID process. In the MS/MSspectrum, most ions are detected 
as y and b ions. 
 
4. Detection and recording of sample ions. 
 The detector monitors the ion current, amplifies it and the signal is then transmitted 
to the data system where it is recorded in the form of mass spectra. The m/z values of the 
ions are plotted against their intensities to show the number of components in the sample, 
the molecular mass of each component, and the relative abundance of the various 
components in the sample. The type of detector is supplied to suit the type of analyser; the 
more common ones are the photomultiplier, the electron multiplier and the micro-channel 
plate detectors.  
 
5. Computational algorithms for peptide identification 
The profiling of proteins in a sample can be achieved by search programmes that 
match the MS/MS spectra of peptides recorded during sample analysis with the theoretical 
spectra. A series of computational methods for the assignment of peptide sequences based 
on automated interpretation of the MS/MS spectra and protein sequence database searching 
have been developed. The search programmes calculate a similarity score that evaluates the 
degree of match between the experimental MS/MS spectrum and a theoretical spectrum 
(e.g., SEQUEST, Thermo Corp., http://www.thermo.com/) or uses a statistical approach to 
evaluate the probability of observing the MS/MS fragment ions (e.g., Mascot, Matrix Science, 
http://www.matrixscience.com/).
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2. Materials  
 2.1.   Chemicals 
Agarose UltraPure™ Invitrogen, Molecular Probes 15510-027 
Agar select Sigma-Aldrich A5054 
Acrylamide(30%)/ 
Bisacrylamide(0,8%)(37.5:1) Carl-Roth 3029.1 
Ammonium persulfate (APS) Sigma-Aldrich A3678 
Ampicillin; Sodium crystalline Sigma-Aldrich A9518 
Ammonium bicarbonate AppliChem A3689.0500 
Acetonitrile VWR 83640.320 
ß-Mercaptoethanol Carl-Roth 4227.3 
Bovine serum albumin, Cohn 
V fraction Sigma-Aldrich A4503 
Boric acid Sigma-Aldrich B0252 
Bromophenol blue Carl-Roth A512.1 
Calcium chloride Carl-Roth A119.1 
Chloramphenicol Sigma-Aldrich C0378 
Complete, Mini, EDTA-free; 
Protease inhibitor Roche 11836170001 
Coomassie Blue G Carl-Roth 9598.1 
1,4-Dithioerythritol (DTE) Sigma-Aldrich 109K1022 
EDTA Sigma-Aldrich E5134 
Ethanol >99.8%, p.a. Carl-Roth 9065.2 
Ethanol denatured (+1% 
Mek) Carl-Roth K928.1 
Ethidiumbromide Carl-Roth HP46.1 
Formic acid MERCK KGaA 1.00264.1000 
Glutathione Sigma-Aldrich G4251 
Glutathione Sepharose 
beads GE/Healthcare 17-0756-01 
Glycerine Carl-Roth 3783.1 
Glycine Sigma-Aldrich G7126 
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Hydrochloric acid Carl-Roth 6331.1 
IPTG Sigma-Aldrich I9003 
Isopropanol AppliChem A0900 
LB Sigma-Aldrich L3022 
Lipofectamine Invitrogen, Molecular Probes 18324012 
Magnesium chloride, 
hexahydrate 
Carl-Roth 2189.2 
Milk powder, blotting grade Carl-Roth T145.2 
Methanol, 99.9% Carl-Roth 4627.2 
Nonidet P-40 Biochemica; distributed by A. 
hartenstein Laborbedarf 
A1694,0500 
PBS buffer (10x Dulbecco´s) 
powder 
Applichem A0965 
Ponceau S Sigma-Aldrich P3504 
Protein-G-Agarose beads Roche 11243233001 
Sodium chloride Sigma-Aldrich S3014 
Sodium dodecyl sulfate Sigma-Aldrich L4390 
Sodium hydroxide pellets Merck 106462 
TEMED Sigma-Aldrich T9281 
Triton X 100 Carl-Roth 3051.3 
Tween 20 AppliChem A1389 
Tris AppliChem A1086, 1000 
Trypsin (Trypsin Gold; MS 
grade) 
Promega V5280 
Trifluoroacetic acid Merck KGaA 1.08178.0050 
 
2.2.   Analytical Kits 
 
Kit Supplier Order Number 
NucleoTrap DNA Gel 
extraction Kit 
Macherey-Nagel 740609.50 
DNA Plasmid Maxi Kit Qiagen 12163 
DNA Plasmid Mini Kit Qiagen 12123 
ECL Western Blotting 
Detection 
GE/Healthcare RPN2109 
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2.3.   Bacterial Strains 
 
Strain Supplier Description Order number 
NEB10 NEB 
Genotype:araD139∆(ara,leu)7697 
fhuA lacX74 galK16 galE15 mcrA 
f80d(lacZ∆M15) recA1 relA1 endA1 
nupG rpsL rph spoT1∆(mrr hsdRMS 
mcrBC) 
C3019H 
E. coli Rosetta Novagen /Merck 
Increased protein expression rate by 
providing tRNAs rarely used in 
E.coli. Genotype: F- ompT 
hsdSB(rB- mB-) gal dcm pRARE 
(CamR) 
70953 
 
2.4.   Eukaryotic cell line 
 
Cell line ATTC number Annotation 
HEK 293 CRL-1573 Human embryonic kidney 
293 cells 
 
2.5.   Expression vectors 
 
Vector Supplier Annotation 
pGEX-4T-1 GE/Healthcare 
Bacterial expression vector. 
Genes cloned into the MCS 
will be expressed as fusions 
to the C-terminus of GST 
pProEX HTb Invitrogen, Molecular Probes 
Bacterial expression vector. 
Genes cloned into the MCS 
will be expressed as fusion 
proteins with an N-terminally 
6xHis tag. 
pcDNA3 Invitrogen, Molecular Probes Mammalian expression vector 
 
pEGFP-C1 
 
Clontech 
Mammalian expression 
vector. Genes cloned into 
the MCS will be expressed 
as fusions to the C-terminus 
of eGFP 
 
2.6.   Enzymes 
 
Enzyme Supplier Order number 
Pfu -Polymerase Promega M774B 
Restriction enzymes NEB - 
T4 DNA ligase (supplied with 
10XReaction Buffer) NEB M0202 
Calf Intestinal phosphatase 
(CIP) NEB 0531005 
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2.7.   Molecular weight standards 
 
Standards Supplier Order number 
DNA ladder 1 Kb PeqLab 25-2031 
DNA ladder 100 bp PeqLab 25-2010 
Precision Plus Protein dual 
colour standard Bio-Rad 
1610374 
 
2.8.   Antibodies 
2.8.1.   Primary Antibodies 
Antigen Antibody Species Supplier Order number 
Working 
dilution 
Anti-myc Myc 9E10 mouse  monoclonal Santa Cruz sc-40 1:500 
Anti-EGFP 
Living-colors 
EGFP A.v 
PeptideAntibody 
Rabbit 
polyclonal Clontech 632376 1:100 
Anti-Spir-2 Anti-Spir-2 antibody 
Rabbit 
polyclonal Lab source  - 1:1000 
 
2.8.2.   Secondary Antibodies 
Antigen Antibody Species Supplier Order number 
Working 
dilution 
Anti-mouse 
anti-mouse IgG 
horseradishperoxidase 
linked 
Sheep 
polyclonal 
Amersham 
Pharmacia 
biotech 
NA 9310 1:5000 
Anti-rabbit 
anti-rabbit IgG 
horseradishperoxidase 
linked 
sheep 
polyclonal 
Amersham 
Pharmacia 
biotech 
NA 9340 1:5000 
 
2.9.   Cell culture media and suppliments 
 
Material Supplier Order number 
DMEM Invitrogen, Molecular Probes 41965039 
L-Glutamine 200 mM Invitrogen, Molecular Probes 25030024 
Poly-L-Lysine; 0,01% 
solution Sigma-Aldrich P 4707 
Trypsin 0,05% EDTA Invitrogen, Molecular Probes 25300054 
PBS Invitrogen, Molecular Probes 14190094 
Fetal calf  serum Fetalclone III Thermo Scientific; Hyclone SH30109.03 
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2.10.   Plastic ware and other materials 
 
Item Supplier Order number 
Blotting papers Grade 3 MM 
Chr Whatman 3030.917 
Cell culture flask (T75)  Sarstedt 83.1813.002 
Cell culture plates 6-Well Greiner Bio-One 657160 
Cell culture glass bottom 
dish Willco wells GWSt-5040 
Conical reaction tubes (15 
ml) Greiner Bio-One 188271 
Parafilm®  `M`  Laboratory 
Film Pechiney Plastic Packaging PM-996 
Pasteur pipettes distributed by A. Hartenstein Laborbedarf PP07 
PCR-tubes (0.2 ml) Axygen, distributed by Abimed PCR-0208-CP-C 
Pipette tips (0.5-10 µl)  Axygen, distributed by Abimed T-300 
Pipette tips (100-1000 µl) Axygen, distributed by Abimed T-1000-B 
Pipette tips (2-20 µl) and 
(20-200 µl) Sarstedt 70.760.002 
Petri dishes (94 x 16 mm) distributed by A. Hartenstein 
Laborbedarf 
PP90 
Reaction tubes (1.5 ml) distributed by A. Hartenstein Laborbedarf RK1G 
Reaction tubes (2.0 ml) distributed by A. Hartenstein Laborbedarf RK2G 
Syringe (1 ml) with needle 
0.45 x 10 mm Becton-Dickinson 300015 
Syringe (10 ml) Braun 4606108V 
Syringe (50 ml) Dispomed 22050 
Syringe filter (0.2 µm) Sartorius Stedim Biotech 17597 
X-ray film FujiFilm 47410 08379 
 
2.11.   Equipments 
Apparatus Supplier 
Autoclave tape (180°C) distributed by A. Hartenstein Laborbedarf 
Autoclave tape (120°C) distributed by A. Hartenstein Laborbedarf 
Neubauer counting chamber Brand 
Centrifuges Eppendorf 
Computer Apple 
Incubator Heraeus, Thermo electron corporation 
Thermocycler Eppendorf 
Gel Documentation system Image Quant 4000, GE Healthcare 
Photometer GeneQuant 1300, GE Healthcare 
Nano-HPLC system Agilent 1100, (Agilent Technologies GmbH, Boeblingen, Germany) 
C18 columns 
(for nano seperations) Nieuwkoop, The Netherlands 
Q-TOF-Mass spectrometer QstarXL, Applied BiosystemsGmbH, Darmstadt, Germany 
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2.12.  Media, Buffers and Solutions 
 
 
Cell culture medium for HEK 293 
 
• 10% FCS 
• 100 U/ml Penicillin 
• 100 µg/ml Streptomycin 
• 0.2 mM L-glutamate in DMEM 
LB Medium for Bacterial propagation 
 
 20g LB broth (with 10g/L Trypton, 5g/L NaCl and 5 g/L Yeast extract) in 1L of dH2O 
 Autoclave for 15 minutes at 121°C. 
 
Buffers and solutions for Protein SDS-PAGE and Western blotting 
 
Seperating Gel 
 
 6.5 % 7.5% 10% 11% 12% 
Dist.Water 6.7 mL 5.7mL 4.8mL 4.5mL 4.1mL 
3M Tris-HCl, 
pH-9.0 1.3mL 1.3mL 1.3mL 1.3mL 1.3mL 
Acrylamide 30 2.3mL 2.6mL 3.5mL 3.9mL 4.2mL 
20% SDS 50µL 50µL 50µL 50µL 50µL 
TEMED 10µL 10µL 10µL 10µL 10µL 
10% APS 50µL 50µL 50µL 50µL 50µL 
 
 
Stacking Gel     
Dist.water 2.6 mL 
1M  Tris-HCl,pH-6.8 420µL 
Acrylamide 30 550µL 
20%SDS 17µL 
TEMED 5µL 
10% APS 33µL 
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10x Running Buffer 
 250 mM  Tris (base)            
 190 mM Glycine           
 0.1% (w/v)  SDS 
 H2O dest 
 
Blotting (Transfer) Buffer  (1.5L) 
 25 mM  Tris (base)            
 192 mM  Glycine  
 20% (v/v) Methanol   
 
Ponceau S  
 0,2 % (w/v) Ponceau S 
 3 % (w/v) Trichloroacetic acid 
 
1X PBS 
 9.5 g 10x PBS powder in 1L H2O dest 
 
PBS-Tween 
 0.05% (v/v) Tween 20 in 1x PBS 
 
Blocking solution (5% Dried milk solution) 
 5 g  Dried milk powder in  100 ml  1x PBST 
 
Stripping buffer   
 62,5 mM Tris   
 2 % (w/v) SDS  
 pH 6,7 
 
1x SDS sample buffer (Protein sample buffer) 
  
 60 mM Tris-HCl pH 6,8   
 10 % (v/v) Glycerin   
 3 % (w/v) SDS 
 5 % (v/v) ß-Mercaptoethanol  
 0,005 % (w/v) Bromophenolblue 
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5x SDS sample buffer (Protein sample buffer) 
 300 mM Tris-HCl pH 6,8   
 50 % (v/v) Glycerin   
 15 % (w/v) SDS 
 25 % (v/v) ß-Mercaptoethanol  
 0,025 % (w/v) Bromophenolblue 
 
Immunoprecipitation buffer 
 
 25 mM Tris, pH 7.4 
 150 mM NaCl 
 1 mM EDTA 
 0.1% (v/v) NP 40 
 10% (v/v) Glycerin 
 
Purification of GST-tagged proteins 
 
Binding buffer  
 2.5 mM Tris pH 7.4  
 1X PBS  
 
Elution buffer  
 20 mM Tris  pH 7.8 
 100 mM NaCl 
 20 mM  Glutathione 
 5 mM DTE 
  
GST Pull down assay 
 
Lysis buffer 
 25 mM Tris  pH 7.4 
 150 mM NaCl 
 1 mM EDTA 
 0.1% (v/v) NP40 
 10% (v/v) glycerol 
 1 mM PMSF 
 Roche-Protease inhibitor cocktail 
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Washing buffer  
 20 mM Tris  pH 7.6 
 50 mM NaCl 
 1 mM EDTA 
 5% (v/v) glycerol 
 1 mM DTE 
 0.1% Triton-X-100 
 Roche-Protease inhibitor cocktail  
 
 Lysis buffer, without EDTA (for GST-Spir-1-KIND/ Myc-Spir-1-CT pull down) 
 25 mM Tris  pH 7.4 
 150 mM NaCl 
 5 mM MgCl2 
 0.1% (v/v) NP-40 
 10% (v/v) glycerol 
 1 mM PMSF 
 Roche-Protease inhibitor cocktail 
  
Washing buffer without EDTA (for GST-Spir-1-KIND/ Myc-Spir-1-CT pull down) 
 20 mM Tris  pH 7.6 
 50 mM NaCl 
 5 mM MgCl2 
 5% (v/v) glycerol 
 2 mM DTE 
 0.1% Triton-X-100 
 Roche-Protease inhibitor cocktail  
 
6x DNA loading buffer  
 
 9 mM Tris-HCl pH 7,4   
 0,45 mM EDTA   
 46 % (v/v) Glycerin   
 0,2 % (w/v) SDS  
 0,05 % (w/v) Bromophenolblue 
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TBE buffer 
 
 0.89 M Tris –Base, pH 8.3  
 25 mM EDTA  
 0.89 M Boric acid 
 
CIP buffer 
 50 mM Tris-HCl pH 7,9   
 10 mM MgCl2 
 100 mM NaCl  
 1 mM DTT 
 
Coomassie (G-250) solution 
 
 0.1% Coomassie Brilliant Blue G-250 
 2% Phosphoric acid 
 5% Aluminium sulphate 
 20% Methanol
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3. Methods 
 
3.1.   Molecular Biology 
 
3.1.1.   DNA amplification by polymerase chain reaction (PCR) 
 PCR is a powerful technique used for the amplification of a specific DNA sequence of 
interest using a DNA polymerase enzyme, like Pfu polymerase and two sequence specific 
oligonucleotide primers that bind to the sense and antisense strands of the DNA template. 
The PCR is commonly carried out in an automated Thermal cycler (Eppendorf) which put the 
reaction through a series of 20-40 cycles of denaturation of DNA template, annealing of 
primers to the DNA template, elongation of the primer catalyzed by the polymerase and the 
final elongation, with three different temperatures. The denaturation temperature is in the 
range of 94-96°C. The annealing temperature is about 3-5 degrees below the Tm (melting 
temperature) of the primers used. The time requred for the elongation is dependent on the 
length of the desired PCR product. For Pfu polymerase 1 minute elongation was sufficient for 
1kb of plasmid length. 
 
3.1.2.   Agarose Gel Electrophoresis 
 Agarose gel electrophoresis is a technique used to identify and separate DNA 
fragments based on their size.  Agarose gel with a concentration of 0.8% is prepared by 
dissolving Agarose (w/v) in 0.5x TBE buffer and boiled in microwave until the agarose is 
dissolved. Afterwards the solution is cooled to 50°C, and supplimented with 0.5 µg/ml of the 
fluorescent DNA-intercalating ethidium bromide. This was poured into the gel trays and the 
combs were inserted. After the soldification of the gel, the trays were put into the 
electrophoresis chamber and the combs were removed. DNA samples were mixed with 6x 
DNA loading buffer, loaded onto the gel and electrophoresis was conducted at 120 volts for 
35 minutes until the blue dye reaches the front of the gel. 1Kb DNA ladder was used to 
determine the size of the DNA fragments which were visualised using a UV transilluminator. 
The fragments were excised and recovered from the gel using NucleoTrap Gel Extract Kit 
(Macherey & Nagel) following the manufacturers´ instructions. 
 
3.1.3.   DNA digestion 
 DNA fragment with specific restriction sites was incubated with restiction 
endonucleases (NEB) following the manufacturers´ recommendations. The exact digestion 
was verified by agarose gel electrophoresis. 
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3.1.4.   Transformation 
Uptake of plasmid DNA into a bacterium is called transformation and the bacterial 
cells that are capable of transformation are called competent cells. Competent cells are 
prepared by treating them with Rubedium chloride (RbCl), which promotes the binding of the 
plasmid DNA to the cell surface which further pass into the cell.  
 Competent E.coli (NEB 10) cells, kept as glycerol stocks, were initially thawed on ice. 
100 µl of the cell suspension was mixed with the DNA sample, gently mixed and kept on ice 
for 45 minutes. The cells were heat shocked for 55 seconds at 42°C and chilled on ice for 2 
minutes. 900µl LB was added and incubated at 37°C for 1 hr with shaking. The cells were 
collected by centrifugation at 6000 rpm for 10 minutes at room temperature. Supernatent was 
discarded and the pellet was resuspended in 150µl LB. 50 and 100µl were plated out on LB 
agar plates containing appropriate antibiotic selection marker and incubated overnight at 
37°C. 
 
3.1.5.   Plasmid DNA preparation  
 A single bacterial colony from the overnight transformants was added to LB medium 
supplimented with appropriate antibiotic were incubated at 37°C for overnight. The cells were 
pelleted and the DNA was isolated using Plasmid Mini Kit and Plasmid Maxi Kit (Qiagen). 
The purified DNA was digested with the desired restriction enzymes. The digested sample 
was loaded on 0.8% agarose gel  and conducted electrphoresis for verification.  
 
3.1.6.   Sequencing 
 DNA plasmids were sequenced by Eurofins MWG/ Operon (Ebersburg). 
 
 3.1.7.   Site-directed Mutagenesis  
Serine136 in pcDNA3-Myc-hs-Spir-2 (Spir-2 full length) and S150 in pGEX-4T1-
NTEV-hs-Spir-1-KIND were mutated to Ala and Glu using QickChange Site-directed 
Mutagenesis Kit. This method is performed using PfuTurbo® DNA polymerase. The basic 
procedure utilizes a supercoiled double stranded DNA (dsDNA) vector with an insert of 
interest and two synthetic oligonucleotide primers containing desired mutation. The primers, 
each complimentary to opposite strands of the vector, are extended during temperature 
cycling by PfuTurbo® DNA polymerase. Incorporation of oligonucleotide primers generates 
mutated plasmid containing staggered nicks.  PCR was carried out in 50µl containing, 50ng 
of DNA to be mutated, 125ng each of 5´ and 3´ primers, 5µl Pfu 10x buffer, 1µl of 10mM 
dNTPs and 1.5µl of PfuTurbo® DNA polymerase in autoclaved water. Thermal cycler carry 
out the reaction through the following settings:  
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1. 95°C for 30sec for the first denaturation of the double stranded DNA template 
2. 95°C for 30sec for the denaturation of the DNA template 
3. 67°C for 1 min for annealing of the primer to the DNA template 
4. 68°C for 1 min/kb of plasmid length elongation. 
The following primers (primer sequence 5´to 3´) were used for Myc-Spir-2- S136A: 
gag agc gag gag cgc gaa ctc gcc cct cag ctg gag cgg ctc atc ; Myc-Spir-2- S136E: gag agc 
gag gag cgc gaa ctc gaa cct cag ctg gag cgg ctc atc ; Myc-Spir-1-KIND-S150E : aag gag aat 
gaa gaa agg gaa tta gag cct ccc cta gag cag ctt atc. 
 The non-mutated methylated DNA template was selectively degraded by DpnI 
endonuclease by adding 1 µL DpnI (10 U/µL) per reaction mixture and incubated at 37°C for 
1 hour. The non-methylated amplified mutation-harboring plasmid was then transformed into 
NEB10. Plasmid DNA was isolated from the transformed colonies by Plasmid Mini and Maxi 
kits and mutations were verified by sequencing. 
 
3.2.   Cell biology 
 
3.2.1.   Cell culture 
HEK 293 cells were grown in Dulbecco´s modified Eagle´s medium supplimented with 
10% fetal calf serum, 2mM L-glutamate, 100U/ml Penicillin and 100µg/ml Streptomycin in a 
humidified atmosphere of 10% CO2 and at a temperature of 37°C. 
 
3.2.1.1.  Poly-L-Lysine coating of culture plates 
Poly-L-lysine is a synthetic aminoacid widely used as a coating to enhance cell to 
improve cell attachment even in reduced and serum free conditions. Culture plates were 
incubated with 10% Poly-L-Lysine solution in H20 dest. for 2-3 minutes at room temperature. 
Afterwards, the solution was removed and wells were allowed to get dried. Before culturing 
the cells in the plates, washing 2 times with 1x PBS is performed.  
 
3.2.1.2.   Transfection 
Transient transfections were carried out by using Lipofectamine according to 
manufacturers´recommendations. Cells were seeded approximately 24 hours before 
transfection in DMEM full medium (10% FCS, Pen/Strep, L-Glu). At the day of transfection 
the cells reached a confluency of 80-90%.  DNA and transfection reagent were suspended in 
DMEM without FCS, Pen/Strep and L-Glu. Appropriate amount of Lipofectamine solution was 
incubated with corresponding concentrations of DNA, for 20 minutes before being added to 
the cells. After 5-6 hr, the medium was changed to DMEM containing FCS, Pen/Strep and L- 
Glu. Cells were allowed to express proteins for 24-36 hours prior to harvesting. 
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3.3.   Protein biochemical methods 
 
3.3.1.   Electrophoretic seperation of proteins 
Polyacrylamide gel electrophoresis (PAGE) is applied to separate protein mixtures 
based on their migration in solution in response to an electric field. Proteins are amphoteric 
compounds. Therefore their net charge is determined by the pH of the solution. Throughout 
the course of this study, protein samples were separated under denaturing conditions using 
anionic detergent, SDS (Sodium dodecyl sulphate), which denature the proteins without 
breaking the peptide bonds. SDS disrupts the secondary and tertiary structure of the proteins 
and confers a negative charge to the polypeptides. Proteins charged negatively by the 
binding of SDS separate within a matrix of polyacrylamide gel in an electric field according to 
their molecular weights. 
 Gels were casted using casting chambers. The casting chamber was filled with 
seperating gel solution and overlaid by isopropanol. Formation of the polyacrylamide matrix 
was done by polymerization reaction of the monomers acrylamide and bisacrylamide induced 
by adding N, N, N’, N’- tetraethylmethylendiamine (TEMED) and the polymerization starter, 
ammonium persulfate (APS). After polymerization, isopropanol was removed and the 
separating gel was overlaid by the stacking gel solution and the combs were inserted. 
Different concentrations of acrylamide were used for separating gels. Gels were placed in gel 
chambers and 1x SDS electrophoresis buffer (Running buffer) was added in the buffer 
chamber. Prior to loading, protein samples were boiled with 1x, 2x or 5x SDS-loading buffer 
and boiled for 5 minutes at 90°C. Electrophoresis was performed at 45 mA at room 
temperature until the bromphenol blue dye reached the bottom of the gel. Protein sizes were 
analyzed using the pre-stained Protein Ladder (Bio-Rad) as molecular weight marker. 
 
3.3.2.   Coomassie staining 
 To visualise the proteins with Coomassie staining, Coomassie Brilliant Blue G-250 or 
R-250 is employed. The former differ from the latter in having two additional methyl groups. 
This staining method is fast but much less sensitive (about 100 ng per protein band) than 
silver staining. After electrophoresis, the gels were dipped in the stain for 15 min with shaking 
and excess stain is removed by gentle agitation with dH2O until the clear band of desired 
protein is viewed. Coomassie Brilliant Blue G-250 is highly compatible with mass 
spectrometry and is therefore employed for staining the gels for the purpose of identification  
of phosphorylation sites by mass spectrometry. Coomassie Brilliant Blue G-250 is able to 
form colloids in acidic media containing ammonium sulfate (Neuhoff et al., 1988) i.e., there is 
a very low concentration of free dye resulting in minimal background staining. The colloids 
act as a reservoir of dye molecules, so that enough dye is present to occupy all binding sites  
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of the proteins, provided that staining is prolonged to the steady state. The electrophoresed 
gel was stained with Coomassie Brilliant blue G250 for overnight and washed with distilled 
water for 4-5 times with gentle shaking. 
 
3.3.3.  Ponceau S staining 
 To control the efficient transfer of the proteins to the nitrocellulose membrane, the 
membrane was incubated in Ponceau solution for 1 minute and gently washed with PBST 
buffer. Afterwards, the membrane was destained in PBST buffer for several times until the 
red colour was completely removed. 
 
3.3.4.   Western blotting and Immunodetection 
Proteins were transferred efficiently from a polyacrylamide gel to a nitrocellulose membrane 
by electroblotting (western blot) using a Sigma blotting tank. The transfer was carried out for 
1.5 hours at 150 mA at room temperature in blotting buffer. Protein transfer was verified by 
staining the nitrocellulose membrane with Ponceau S solution for 1 minute at room 
temperature followed by rinsing the membrane with distilled water 2-3 times to reveal the 
protein distribution on the nitrocellulose membrane. Thereafter, the membrane was 
destained with PBS-Tween (PBST) until staining faded away completely. For 
immunodetection, the nitrocellulose membrane was blocked over night in blocking buffer (5% 
Milk solution) at 4°C. After blocking, the membrane was incubated in blocking buffer 
containing the corresponding primary antibody for 1.5 hour at room temperature. 
Subsequently, the membrane was washed 3 times with PBST for 10 min at room 
temperature with shaking. Further the membrane was incubated in PBST: blocking buffer 3:1 
(v/v) containing the secondary HRP-linked antibody for 35 minutes at room temperature, 
followed by a second washing as described above. Detection was performed with an ECL 
reagent kit (Enhanced Chemiluminescence, GE Healthcare) and experimental datas were 
digitalized with an ImageQuant LAS 4000 CCD camera imaging system and a PeqLab gel 
documentation system which was further processed with Adobe Photoshop. 
 
3.3.5.   Blot stripping 
Membrane stripping is the removal of primary (1°) and secondary (2°) antibodies from 
a western blot membrane to allow the incubation of new 1° and 2° antibodies for the assay of 
new protein by western blot. Western blot stripping buffer removes both the antibodies 
without removing or damaging the immobilized antigen. This allows blots to be stripped and 
reprobed. Blot stripping buffer is prewarmed at 50°C. The nitrocellulose membrane to be 
stripped, is incubated with stripping buffer for 15 minutes at 50°C. This is repeated for 2 more 
times. After the third incubation, the membrane is washed with 0.05% PBST, 4 times for 10  
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minutes and blocked in blocking solution overnight before being reprobed by corresponding 
antibodies. 
 
3.3.6.   Recombinant protein expression in prokaryotes 
 The expression of the fusion protein may be affected by a variety of factors such as 
the (a) E. coli strain, (b) cell growth conditions (e.g. temperature, aeration, cell density, IPTG 
concentration, etc.), (c) toxicity of the target protein, (d) codon usage and (e) structure and 
stability of mRNA. For the prokaryotic expression of proteins, the E.coli strain Rosetta 
(Novagen) has been used. Rosetta strains are BL21 derivatives designed to enhance the 
expression of proteins that contain codons rarely used in E.coli. These strains supply tRNAs 
for AGG/AGA (Arginine), AUA (Isoleucine), CUA (Leucine), CCC (Proline) and GGA 
(Glycine), codons on a compatible chloramphenicol-resistant plasmid, pRARE. By supplying 
rare codons, the Rosetta strains provide for ″universal″ translation, where translation would 
otherwise be limited by the codon usage of E.coli. Protein expression is under the control of 
the lacZ promotor and is induced by the lactose analog isopropyl-ß-D-thio-galactoside 
(IPTG). IPTG binds to the repressor and inactivates it, but is not a substrate for β-
galactosidase. As it is not metabolized by E. coli, its concentration remains constant. 
Therefore the expression rate of the recombinant protein is also constant. 
3.3.6.1.   Expression and purification of GST-tagged recombinant proteins 
 Glutathione-S-transferase (GST) from Schistosoma japonicum is used as tag for 
proteins for expression and purification applications. GST is a 26 KDa protein which binds to 
glutathione with high affinity and specificity. Recombinant proteins fused to GST can then be 
selectively purified based on its high affinity for immobilized glutathione (glutathione 
sepharose). Sepharose is a bead form of agarose. The binding occurs under 
nondenaturating conditions since GST loses its ability to bind glutathione sepharose when 
denatured. The cDNA of interest cloned into pGEX-4T1-NTEV was used. 
Procedure : Expression and purification of GST-fusion proteins for GST-pull down 
assay (GST-Fmn2-eFSI, GST-Spir-1-KIND and GST-Spir-1-KIND-S150E)  
 Escherichia coli Rosetta pLysS bacteria were transformed with plamid encoding GST-
tagged Spir and formin constructs. Initially, the recombinant bacteria were grown in LB 
medium with 10% Ampicillin (1:1000) and 34 mg/liter Chloromphenicol (1:1000) at 37° C with 
shaking (160 rpm). The next day 200 ml of LB medium with 10% Ampicillin (1:1000) and 34 
mg/liter Chloromphenicol (1:1000) was inoculated with primary culture (10:1) and incubated 
at 37°C with shaking at 160 rpm until A 600 ~ 0.5 – 0.6 is reached. When the desired OD is 
reached, the temperature was lowered to 21°C and protein expression was  
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induced with 120µM IPTG and allowed to proceed at 21°C for overnight. Cells were 
harvested at 4000 x g for 20 minutes at 4° C and the pellet were resuspended in buffer A 
(2.5 mM DTE in 1x PBS, pH 7.4). Bacteria were lysed by ultrasonication and centrifuged at 
20000 x g for 30 minutes at 4°C. The high speed supernatant were incubated with 300 µL 
GSH- Sepharose 4B resin (GE Healthcare) for 2h-overnight at 4°C on a rotating wheel. The 
beads were washed 5 times with buffer A and proteins were eluted with 600 µL of elution 
buffer (20 mM Tris, pH 7.8, 100 mM NaCl, 20 mM glutathione and 5 mM DTE). Proteins were 
concentrated by ultrafiltration using Amicon Ultra-4 ultracentrifugation devices with molecular 
mass cut offs of 10000 Da (Millipore). Protein concentration was measured by Bradford 
method using bovine serum albumin as standard. Fractions were collected, stored at – 20°C. 
Aliquots of the fractions were analyzed by SDS-PAGE followed by Coomassie staining. 
 
3.3.7.   Methods for the detection of protein-protein interactions 
  Since protein-protein interactions are intrinsic to every cellular processes and carries 
extreme relevance, there are a multitude of methods to detect them. Each approaches has 
its own advantages and disadvantages regarding the sensitivity and specificity. The study 
make use of two methods: Pull down assays and Immunoprecipitation. 
3.3.7.1.   GST fusion protein pull-down technique. 
 As a relatively easy and straightforward method to confirm the known protein-protein 
interactions and to map the interaction sites, it is worthwhile to employ pull-down assays. 
Glutathione-S-transferase (GST) fusion proteins have had a range of applications since their 
introduction as tools for synthesis of recombinant proteins in bacteria. GST pull-down 
experiments are used to identify interactions between a probe protein and unknown targets 
and to confirm suspected interactions between a probe protein and a known protein. The 
probe protein is a GST fusion protein whose coding sequence is cloned into an IPTG –
inducible expression vector. This fusion protein is expressed in bacteria and purified by 
affinity chromatography on GSH-Sepharose beads. The target proteins are usually lysates of 
cells. The cell lysate and the GST fusion protein are incubated together with GSH-Sepharose 
beads. Complexes recovered from the beads are resolved by SDS-PAGE and analyzed by 
western blotting or staining.  
For GST Pulldown experiments with the GST-Fmn2-eFSI / Myc-hs-Spir-2 and GST-
Spir-KIND domains / EGFP-tagged Spir-1-FYVE. 50µg of purified GST/GST fusion protein 
bound to 13µl of GSH-Sepharose 4B resin (GE Healthcare) were used. Cell lysates were 
prepared by lysing ~36 x 105 HEK 293 cells in 900 µl of Lysis buffer (25 mM Tris pH 7.4, 150 
mM NaCl, 1 mM EDTA, 0.1%(v/v) NP40, 10%(v/v) Glycerol, 1 mM PMSF ; which was also 
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 supplemented with one tablet of Protease inhibitor mixture (Roche Applied Science) per 7ml 
of buffer) at 4°C. Care should be taken to avoid EDTA from lysis and washing buffer when 
dealing with HEK 293 transfected with Spir-CT. The lysate was centrifuged at 20,000×g for 
20 minutes at 4°C. 50µg of GSH-Sepharose 4B- bound GST fusion proteins were incubated 
with the high speed supernatant of the cell lysate for 2 hours at 4°C. Beads were gently 
washed 4 times with Washing buffer (20 mM Tris pH 7.6, 50 mM NaCl, 1 mM EDTA, 5% (v/v) 
Glycerol, 1mM DTE, 0.1% (v/v) Triton X- 100; supplemented with 1 tablet of Protease 
inhibitor mixture per 7 ml of buffer) and boiled in 2x SDS protein sample buffer. The samples 
were subjected to SDS-PAGE followed by Western blot analysis. c-Myc-9E10 mouse 
monoclonal antibody (1:500 ; Santa Cruz Biotechnology, Inc.) and anti-Spir-2 antibody 
(1:1000 ; Lab stock), rabbit A.V- living colors antibody (1:100; Takara/Clontech) were used 
as primary antibodies, which were detected with horseradish peroxidiase- conjugated anti-
mouse and anti-rabbit secondary antibodies (1:5000 ; GE Healthcare) respectively, and 
visualized with the enhanced chemiluminescence kit (GE Healthcare). Experimental datas 
were digitalized with an ImageQuant LAS 4000 CCD camera imaging system and a PeqLab 
gel documentation system which was further processed with Adobe Photoshop.  
3.3.7.2.   Immunoprecipitation (IP) 
  IP is a technique of precipitating a protein antigen out of solution using an antibody 
that specifically binds to that particular protein. The present study makes use of the indirect 
method of IP in which antibody that is specific for the particular protein are directly added to 
the mixture of proteins. The Protein G agarose beads are then added to the mixture of 
antibody and the protein, so that antibody bound to the targets will stick to the beads. One of 
the major technical hurdles with IP is the difficulty in generating an antibody that specifically 
target a single known protein which can be overcome by using tags onto either N- or C-
terminal end of the protein of interest. Target proteins used in the study is Myc-tagged and to 
immunoprecipitate them anti-Myc 9E10 antibody is used. HEK293 cells (3 x 105 per well) 
were seeded in a 6-well plate one day before transfection. Cells were transfected  with Myc-
Spir-2 alone and together with Myc-JNK-MKK7. 24 hours post-transfection the cells were 
lysed with 333µl immunoprecipitation buffer (25 mM Tris, pH- 7.4, 150 mM NaCl, 1 
mMEDTA, 0.1% (v/v) NP40 and 10% glycerol). The cell lysate was centrifuged for 5 minutes 
at 40,000 rpm at 4°C. Anti-myc-9E10 antibody was added to the cleared supernatent to a 
final concentration of 4 µg/ml and incubated for 1 h on ice. 30µl of Protein- G-Agarose 
(Roche) beads was added, and the sample was rotated for 2 hours at 4°C. The beads were 
washed three times with IP buffer and the reaction was stopped by boiling the beads in 1x 
SDS protein sample buffer. The samples were resolved by SDS-PAGE and detected by 
Western blotting. 
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3.3.8.   Phosphatase assay 
HEK 293 cells were transfected with Myc-Spir-2 in presence and absence of JNK-
MKK7 using Lipofectamine following manufacturers´ ́instructions. After 24 hours post- 
tansfection, the cells were harvested in immunoprecipitation (IP) buffer and were further 
undergone immunoprecipitation with anti-Myc-antibody (4µg/ml) for 1hour in ice. The 
complex is incubated with 30 µl Protein-G-Agarose beads (Roche) for 2 hours at 4°C on a 
rotating wheel. The beads were washed 3 times with IP buffer and after the last washing the 
beads were resuspended in CIP buffer (50 mM Tris- HCl, pH-7.9, 10 mM MgCl2, 100 mM 
NaCl and 1 mM DTT). 10 units of Calf Intestinal Phosphatase (CIP; 10,000U/ml) was added 
to 25µl beads suspension and incubated at 37°C for 1 hour. Reaction was stopped by the 
addition of 40µl of 1X SDS sample buffer and heated for 5 mins at 90°C. The samples were 
subjected to 7.5% SDS-PAGE followed by western blotting using anti-Myc-antibody. 
 
3.4.   Fluorescence anisotropy 
Anisotropy is a measure of the correlation between polarization aof fluoresence 
excitation and emission. The anisotropy is maximal when a fluorophore is absolutely fixed in 
space. Fluorescence anisotropy can be used for measuring the binding interaction between 
two molecules, to determine the binding constant (or the inverse, the dissociation constant) 
for the interaction. Protein interactions can be detected when one of the interacting partners 
is fused to a fluorophore. Upon binding of the partner molecule a larger, more stable complex 
is formed which will tumble more slowly (thus, increasing the polarization of the emitted light 
and reducing the "scrambling" effect). This technique works best if a small molecule is fused 
to a fluorophore and binds to a larger partner (this maximizes the difference in signal 
between bound and unbound states). If the fluorophore is attached to the larger protein in a 
binding pair, the difference in polarization between bound and unbound states will be smaller 
(because the unbound protein will already be fairly stable and tumble slowly to begin with) 
and the measurement will be less accurate. Fluorescence anisotropy measurements were 
performed in a Horriba Jobin Yvon Fluoromax-4 spectrophotometer in anisotropy buffer (10 
mM Hepes, pH 7.0,100 mM NaCl) at 20 °C. Proteins for anisotropy measurements, were 
labelled on cysteines with the thiol reactive maleimidocaproyl-linked BodipyFL™-fluorophore  
(Probes). Proteins were buffer exchanged into labelling buffer (10mM Hepes, pH 7.0, 100mM 
NaCl, 0.25 mM Tris (2-carboxy-ethyl) phosphine) using Nap 10 columns (GE Healthcare). A 
2-fold molar excess of the dye was coupled with the protein (1-5g/L) for 16-18 h at 4°C. 
Excess non-reacted dye was quenched with 20mM dithioerythritol and subsequently 
removed using Nap 10 columns. The BodipyFL™ fluorophore was excited at 495 nm, and 
emission was collected at 510 nm, with an integration time of 2s for the Bodipy-labelled  
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formin peptides (100 nM) and 4s for the BodipyFL™-labeled Spir-1-KIND domain (100 nM). 
The slit width of the emission and excitation monochromators was set to 2 nm for the Bodipy-
FLTM-labeled formin peptides and 3 nm for the labeled Spir-1-KIND domain, respectively. 
Each data point of the binding curve which is the mean of at least eight collected polarization 
signals. Data analysis and processing was done with Sigma Plot 9.0 (Systat Software).  
 
3.5.   Mass Spectrometry measurements   
Gel bands in the Coomassie staining (Coomassie Brilliant Blue G250) corresponding 
to the phosphorylated and non-phosphorylated fragments of Spir-2 protein, were excised and 
washed according to Shevchenko et al. (1996). Briefly, gel pieces were washed 3 times 
alternatively with 50µl of 50 mM ammonium bicarbonate and 25 mM ammonium bicarbonate 
in 50% acetonitrile. Subsequently, the gel slices were dried in vaccum centrifuge. 5µl of 
Trypsin solution (12.5 ng/µl in 50 mM ammonium bicarbonate) were added to each gel piece 
and incubated at 37°C overnight for in-gel digestion. The obtained peptides were eluted with 
20µl of 5% formic acid and subjected to nano-liquid chromatography-MS/MS analysis. 
Therefore, an Agilent 1100 nano- HPLC system (Agilent Technologies GmbH, Boeblingen, 
Germany) was used. The samples were pre- concentrated on a 100 µm inner diameter, 2cm 
C-18 column (Nanoseperations, Nieuwkoop, The Netherlands) using 0.05% trifluroaceticacid 
with a flow rate of 8ml/minute. The peptides were then separated on a 75µm inner diameter, 
15cm, ZorbaxSB300-C18-column (flow rate 300µl/minute; Agilent Technologies GmbH, 
Boeblingen, Germany) using a 2h binary gradient from 5-50% solvent B (Solvent A: 0.2% 
formic acid; Solvent B: 0.2% formic acid, 84% acetonitrile). The nano-HPLC was directly 
coupled to QTOF-mass spectrometer (QStar XL, Applied Biosystems GmbH, Darmstadt, 
Germany) acquiring repeatedly one full-MS and two tandem-MS spectra of the most 
intensive ions in the respective full MS scan. The tandem-MS spectra were searched against 
the SwissProt database using Mascot algorithm version 2.2 (Matrix Science Ltd., London, 
UK) using the following adjustments: trypsin as protease, one missed cleavage site, 
oxidation of methionine, phosphorylation of serine, threonine and tyrosine, pyroglutamic acid 
for N-terminal Gln as variable modifications, 0.2 Da tolerance for MS and MS/MS signals, 
and only doubly and triply charged ions. 
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4. Results 
 
4.1.   Phosphorylation of human Spir-2 
 
4.1.1.   Identification of phosphorylation sites in human Spir-2 
Drosophila p150-Spir was found to be a phosphorylation target of JNK activity and it 
was also observed that JNK-MKK7, a constitutively active form of JNK, induces an 
electrophoretic mobility shift of p150-Spir as a result of protein phosphorylation (Otto et al, 
2000). Still, the sites of phosphorylation were not known yet. In analogy to these facts, this 
study carries the interest to elucidate the phosphorylation profile of mammalian Spir proteins 
by employing a contemporary mass spectrometric (MS) approach. All the phosphorylation 
experiments are carried out with Myc tagged human-Spir-2 protein (Myc-hs-Spir-2) together 
with the constitutively active JNK-MKK7 kinase. As a prerequisite to get the Spir-2 protein for 
the MS analysis, Spir-2 was expressed in HEK 293 cells and subsequently pulled down 
using purified GST-tagged Fmn-2-eFSI in a conventional GST-pull down assay, which was 
performed based on the fact that mammalian Spir proteins (Spir-1/2) interact with 
mammalian formin proteins (Fmn-1/2) and the interaction is mediated by N-terminal Spir 
KIND domain and formin-2 formin Spir interaction sequence (FSI) with flanking sequences N-
terminal to it (eFSI) (Pechlivanis et al., 2009). Later on, both the phosphorylated as well as 
non-phosphorylated fragments of Spir protein were identified in Coomassie staining as well 
as in Western blotting. Initially GST-Fmn-2-eFSI was expressed and purified to perform the 
pull-down experiment. 
  
4.1.1.1.   Expression and purification of GST-Fmn-2-eFSI 
As a preliminary step for the GST pull-down assay, GST-Fmn-2-eFSI fusion protein 
was purified. E.coli Rosetta strain was transformed with a GST-Fmn-2-eFSI expression 
vector and expression was induced with 0.1mM IPTG at 21°C (→ 3.3.6.1). Cells were 
harvested, sonicated and the clear supernatent was incubated with Glutathione (GSH) –
Sepharose 4B beads. The beads and associated proteins were undergone repeated spin 
down and resuspension cycles and afterwards the protein was eluted from the beads and 
concentrated via an Amicon Ultrafiltrate device. The concentration was determined by a 
Bradford assay and the purified GST-Fmn-2-eFSI protein corresponding to the size of 33KDa 
was identified in coomassie staining (Figure 4.1.1.1) which was further on used for the 
GSTpull-down assay with Spir-2 protein. 
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Figure 4.1.1.1  Expression and purification of GST-Fmn-2-eFSI.  GST-Fmn-2-eFSI was expressed 
in Rosetta and the expression was induced using 0.1mM IPTG at 21°C. The cells were harvested, 
sonicated and centrifuged. Supernatent and pellet fractions are from the high speed centrifugation of 
the sonicated cell lysates. The clear supernatent was coupled to GSH-Sepharose beads. The beads 
were washed and the protein was eluted and concentrated via Amicon Ultra4 centrifugation devices. 
SDS-PAGE was conducted on a 10% Polyacrylamide gel and the protein was visualized using 
Coomassie staining. The band of GST-Fmn-2-eFSI protein is indicated. 
 Abbreviations: M, Marker; KDa, kilo Dalton; to, non-induced control; t1, induced control. 
 
4.1.1.2.   Interaction between Spir-2 and Fmn-2 
To purify transiently expressed Spir-2 from HEK 293 cell lysates, a GST pull-down 
assay was performed. HEK 293 cells were transiently transfected with plasmid encoding 
Myc-hs-Spir-2 (pcDNA3-Myc-hs-Spir-2 (full length)). After 24 hours transfection, total cell 
lysates were made in 900µl of chilled pull-down buffer. The lysate was centrifuged at 20,000x 
g for 20 minutes at 4°C. 50 µg each of purified GST-Fmn-2-eFSI and GST (as control) 
proteins were allowed to get bound to 13µl of GSH-Sepharose 4B beads (→ 3.3.7.1) for 1 
hour. Beads were gently washed with the pull down buffer and incubated with the high speed 
supernatant of the cell lysate for 2 hours at 4°C. Beads were again washed for 4 times at 4 
°C at 500 x g and boiled in 2x SDS protein sample buffer at 95°C for 5 minutes. The pulled 
fractions were subjected to SDS-PAGE followed by western blotting using anti-Myc antibody 
as primary antibody and a horseradish peroxidase-conjugated anti-mouse secondary 
antibody. The bands were visualized with the Enhanced Chemiluminescence Kit 
(Amersham). The blot reveals the interaction between Spir-2 and Fmn-2 (4.1.1.2 B).   
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Figure 4.1.1.2.  Interaction between Spir-2 and Fmn-2. A. Domain organizations of hs-Spir-2 
(GenBank accession No: CAD19439.1) and mm-Fmn-2 (Swiss-Prot entry No: Q9JL04.2) 
Abbreviations: KIND, Kinase non-catalytic C-lobe domain; WH2, WASP homology-2 domain; FYVE, 
modified FYVE Zn finger; FH1, Formin homology 1 domain; FH2, Formin homology 2 domain; FSI, 
Formin-Spir Interaction sequence; eFSI, FSI with flanking sequences from FH2 (aa1523-aa1578); aa, 
aminoacid B. GST protein alone or GST-protein fused to Fmn-2-eFSI (GST-Fmn-2-eFSI) have been 
coupled to Glutathione-Sepharose beads and incubated with HEK 293 cell lysates expressing Spir-2. 
The proteins expressed in the cell lysates were pulled down in a GST pull-down experiment with 
purified GST-Fmn-2-eFSI and GST bound to GSH-Sepharose 4B beads, were detected by 
immunoblotting using anti-Myc antibody. HEK NT is HEK 293 cells non-transfected with Spir-2 and is 
used as control. 
 
4.1.1.3.   Spir-2 is phosphorylated by JNK-MKK7 
The next step was to address the question, whether mammalian Spir is 
phosphorylated. To cross over this question, the same pull-down assay as above was 
employed but with the involvement of JNK-MKK7, so as to know the effect of JNK-kinase on  
phosphorylation. Briefly, HEK 293 cells were transiently transfected with Spir-2 alone and  
together with JNK-MKK7 in order to compare the electrophoretic mobility, if there is any. 24  
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hours post-transfection the cell lysates were collected, sonicated, centrifuged and the clear  
supernatent was incubated with purified GST and GST-Fmn-2-eFSI. Afterwards pull-down 
assay was conducted as above. The pulled fractions were resolved in SDS-PAGE followed 
by western blotting with Anti-Spir-2 antibody and horseradish peroxidase conjugated anti-
rabbit antibody as primary and secondary antibodies respectively and visualized using 
Enhanced Chemiluminescence Kit. 
JNK-MKK7 induced an electrophoretic mobility shift of Spir-2 indicating 
phosphorylation of Spir-2 (Figure 4.1.1.3 B). Two prominent bands were observed 
corresponding to the molecular weight of non-phosphorylated and phosphorylated fragments 
of Spir-2 protein which strongly suggests the phosphorylation of Spir-2 protein in response to 
JNK-MKK7. There was no interaction between Spir-2 and GST protein alone. 
 
 
Figure 4.1.1.3.  Phosphorylation of Spir-2 by JNK-MKK7.  A. Structure of the JNK–MKK7 fusion 
protein. Amino acids 2–426 of rat JNK3 (GenBank accession No. ABD24063) were fused via an (EG)5 
linker peptide (L) to amino acids 2–346 of mouse MKK7 (GenBank accession No: AF026216). In 
addition, a Myc epitope tag (aminoacids 410–419 of c-Myc; M) was fused to the amino terminus of the 
protein (modified from Otto et al., 2000). B. GST protein alone or GST-protein fused to Fmn-2-eFSI 
(GST-Fmn-2-eFSI) have been coupled to Glutathione-Sepharose beads and incubated with HEK 293 
cell lysates expressing Spir-2 alone and along with JNK-MKK7. The proteins expressed in the cell 
lysates were pulled down in the GST pull-down experiment with purified GST-Fmn-2-eFSI and GST 
bound to GSH-Sepharose 4B beads, were detected by immunoblotting using a rabbit polyclonal anti-
Spir-2 antibody. 
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4.1.1.4   Identification of phosphorylated residues in Spir-2  
To confirm the phopshorylation as well as to identify the phopshorylation sites, a 
mass spectrometrical approach was employed. 
Gel electrophoresis of protein samples, trypsin digestion of target proteins and 
analysis of the resulting peptide fragments by Mass Spectrometry (MS) comprise a powerful 
method for protein identification and characterization. A fluorescent, coomassie or silver stain 
is necessary to visualize proteins that have been separated in 1-D or 2-D gels. Processing 
such samples for mass spectrometry necessitates first excising the protein spot of interest, 
removing the stain, digesting and eluting the protein in the gel piece using an in-gel tryptic 
digestion which is the most commonly used procedure.  
Accordingly, the same pulled fractions which showed the phosphorylation status of 
Spir-2, were again subjected to SDS-PAGE followed by staining with Coomassie Brilliant 
Blue (CBB) G-250 (Figure 4.1.1.4) to visualize the protein fragments, followed by MS 
analysis to confirm the phosphorylation site assignment of the protein. 
 
 
 
Figure 4.1.1.4  Coomassie staining 
of GST-Fmn-2-eFSI/Spir-2 (-/+JNK-
MKK7) pull down.   
SDS-PAGE gel of the pulled fractions 
comprising both phosphorylated and 
non- phosphorylated fragments of Spir-
2, alone and along with JNK-MKK7, 
from the GST-pull down assay, stained 
with Coomassie Brilliant Blue G-250. 
Pull-down of Spir-2, with and without 
JNK-MKK7 from purified GST protein is 
also shown as a control. 
 
 
 
Likewise the Westernblot from the pull down experiment, coomassie staining of the 
SDS-PAGE gel with the same pulled fractions came up with two sharp bands corresponding 
to the coexpression of Spir-2 protein along with JNK-MKK7 pulled from purified GST-Fmn-2-
eFSI protein. On the otherhand, only a single sharp band is clearly visible which points to the 
pulled sample containing Spir-2 alone. These facts empower the study to move further with 
the MS analysis. 
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4.1.1.5.   LC-MS/MS analysis of Spir-2 protein  
MS has become a powerful technology for proteomics and is evolved as a method of 
choice for unbiased analysis of protein phosphorylation. To identify the phosphorylation sites, 
the study make use of nano-LC-MS/MS (Liquid chromatography-Tandem mass 
spectrometry) instrumentation which provide high sensitivity and good reproducibility.  
Prior to the entry into MS, the gel bands corresponding to both the potentially 
phosphorylated and non-phosphorylated fragments of Spir-2 were excised carefully, washed  
and performed in-gel tryptic digestion (→ 3.5). The resulting peptide mixture is eluted with 
formic acid and further fractionated by nano-scale high performance liquid chromatography 
(HPLC) systems (Agilent 1100) that are directly linked to the inlet of the mass spectrometer 
which allows on-line detection and analysis of peptides. The liquid effluent containing the 
peptides eluted from the chromatography column is then electrostatically dispersed to 
multiply−charged analyte ions by Electrospray ionisation (ESI). Following ionization, the 
analyte ions are seperated by mass analyzer and finally detected.  
The mass analyzer, QTOF (Quadrapole Time of Flight) enables the ions formed in the 
ionisation source of the mass spectrometer to get resolved according to their mass-to-charge 
(m/z) ratios. The detector monitors the ionic current, amplifies it and the signal is then 
transmitted to the data system where it is recorded in the form of mass spectra. For protein 
identification, acquired mass spectra are typically compared to a database that contains all 
possible protein sequences. The tandem-MS spectra were searched against the Swiss-Prot 
data base (human nr) using the Mascot algorithm version 2.2. 
 MS/MS spectra of the phosphopeptides obtained in the analysis identified three 
individual phosphorylated Serine residues, S136, S456 and S636 (Figure 4.1.1.5 B/C/D and 
Table 1). Assignment of phosphorylation sites was verified by manual inspection of the 
tandem mass spectra. The results established the phosphorylation of S136, S456, and S636 
which were identified for the first time in Spir-2 protein.  
 To identify post-translational modifications, it is important to obtain good sequence 
coverage. The peptide sequence data correspond to an accumulated aminoacid sequence 
coverage of 67%, resulted after the tryptic digestion (cut at C-terminal of Lys and Arg 
residues) (Figure 4.1.1.5 A). 
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Figure 4.1.1.5 A.   Illustration of Spir-2 sequence coverage by nano-LC-MS/MS analysis.  MS/MS 
spectra files were searched against MASCOT search engine. Aminoacid sequence coverage (red 
colour) obtained by nano-LC-MS/MS analysis of peptide mixtures after the digestion with trypsin (cut 
at K-X or R-X; X is any aminoacid). The aminoacid sequence coverage was determined to 67%. 
Verified phosphopeptide regions in the tryptic digests are underlined. 
 
The peptide, 134EL[pS]PQLER141, is found to be mono phopshorylated and the mass 
difference between y6 (711.325) and y5 (642.299) represents phopshoserine indicating S136 
is phopshorylated. The prominent neutral loss (-97 Da) is a common phenomenon for the 
peptides those are phopshorylated on Ser or Thr. ´y´ ions containing phopshorylated Ser  
featured loss of 98 Da due to the elimination of phosphoric acid. 
 The above fact is applicable to the remainig two peptides as well. The peptide 
454SF[pS]EHDLAQLR464, is monophosphorylated carrying a phosphorylated Ser residue at 
the site 456. The difference between b3 (304.100) and b2 (235.083) is an indication of Ser 
phosphorylation since the result is indicating the loss of 18Da (H2O loss). The difference 
between y4 (470.00) and y3 (400.209) in the spectra 624FGHIPVYTLGFE[pS]PQR639 also 
points to a loss of 18 Da from the molecular weight showing Ser phopshorylation.                                                                                                                                           
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Figure 4.1.1.5 B. 
 
Figure 4.1.1.5 C 
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Figure 4.1.1.5 D 
 
Figure 4.1.1.5 B/C/D  Peptide Spectra of three phopshorylated peptides in Spir-2. Automatic 
nanoflow LC-MS/MS analysis of Spir-2 identified three phopshorylated peptides and three 
phopshorylation sites in each. MS/MS peptide sequence data established the presence of phosphate 
groups on S136, S456 and S636. N and C-terminal peptide fragment ions (b-ion (in green) and y-ion 
(in blue) series respectively) are indicated. ´y´ ions containing phosphorylated Ser, featured loss of 98 
Da due to the loss of phosphoric acid are shown. 
 
Conjointly, nano-LC-MS/MS analysis allowed the identification of three phospho-
peptides with one in N-terminal KIND domain and the others in C-terminus of Spir-2 protein, 
locating one Ser phosphorylation sites in each peptides (Table 1). 
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Table 1. Phosphopeptides identified and sequences by mass spectrometry 
 
 
  Peptide sequence                                                                                Phosphorylation sites 
 
1.  134- EL[pS]PQLER- 141                                                                                 S136 
2.  454- SF[pS]EHDLAQLR- 464                                                                          S456 
3.  624- FGHIPVYTLGFE[pS]PQR-639                                                                S636 
 
 Phosphopeptides identified in phosphorylated Spir-2 protein by nano-LC-MS/MS analysis of 
tryptic digests.  
     
Among the three Ser phosphorylation residues, S136 is found to be localized in the 
KIND domain of Spir-2, which is a putative protein interaction module. Interestingly, this site 
is conserved among the Spir family of proteins (Figure 4.1.1.5 E), raising the possibility that 
this site serve a functional guise.  
 
 
 Figure 4.1.1.5 E  Sequence alignment of a part of KIND domain of Spir family proteins mapping 
the S136 phosphorylation site.  Sequence alignment of a portion of N-terminal KIND domain of Spir 
family members mapping the singly phosphorylated peptide ELpSPQLER in Spir-2 protein pointing 
S136 phosphorylation site which is conserved among Spir family proteins. In mammals S136 is 
immediately succeeded by Proline. The sequences were aligned by a ClustalW mutiple sequence 
alignment and manually realigned when necessary. Abbreviations : KIND, Kinase non-catalytic C-lobe 
domain; JNK, c-Jun-N terminal kinase; Ser, Serine and Thr, Threonine 
 
JNK MAP kinases are recruited to substrate proteins via docking sites, enabling the 
kinases to phosphorylate serine or threonine residues adjacent to prolines (S/TP motifs) 
(Jacobs D et al., 1999). Since S136 residue of Spir-2 is immediately followed by a proline in 
all mammalian Spir proteins, leads to the conclusion that S136 could be definitively assigned 
as a positive target motif for JNK in mammalian Spir proteins, whereas the respective site is  
not the highest confidence assignment in Drosophila and Ciona Spir (PEM-5), as the 
corresponding serine is not followed by a proline. Thus the residue following S136 of Spir-2  
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confirm JNK consensus sequence. The fact that, phosphorylation on S136 is specifically  
induced by JNK-MKK7 was confirmed using Extracted ion chromatogram, taking the peptide 
containing S136. Extracted ion chromatograms of the peptide containing S136, in presence 
and absence of JNK-MKK7 were integrated. The abundance of phosphorylation of S136 was 
found to be huge in presence of JNK-MKK7 when compared to that in the absence of the 
same kinase (Figure 4.1.1.5 F). 
The above features reveals that the Ser136 found in the Spir KIND domain, which is 
typically involved in protein-protein interactions, and phosphorylation in this domain may 
regulate the ability of Spir proteins to bind to it´s interacting protein partners. 
  
 
Figure 4.1.1.5 F   Extracted ion chromatogram for S136 containing peptide.  The extracted ion 
chromatogram showing the abundance of phopshorylation on S136 in the N-terminal KIND domain of 
Spir-2, in presence and absence of JNK. The chromatogram shows that the S136 exhibit a high rate of 
phosphorylation when Spir-2 is expressed together with JNK-MKK7. 
 
The second identified phosphorylation site in Spir-2 protein, S456, is located in the C-
terminal half of the protein, specifically in the linker region between the WH2 domain and the 
Spir-box. This site is found as not conserved among the Spir family proteins and is specific 
for mammalian Spir-2 proteins. However, theoretically, this site can not be assigned as  
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definitively assigned motif for JNK since it did not satisfy the consensus sequence residue 
(ST/P) following the S456 site (Figure 4.1.1.5 G, upper panel). Eventhough this site is 
outside of any described domains of the proteins, it may not imply a lack of functional 
significance. 
The third Ser phosphorylation site is found to be Ser636, which resides in the FYVE 
Zn-finger domain. It is also not a conserved site and is specific for mammalian Spir-2 protein 
(Figure 4.1.1.5 G, lower panel). But in Spir-2 this site is immediately followed by Proline, 
which is not the case in mouse homologue. FYVE domains are membrane binding modules. 
The Spir proteins are specifically recruited to endosomal membranes by a FYVE zinc finger 
membrane localization domain which makes point to investigate the role of this 
phosphorylation site in the membrane targeting and intracellular membrane transport. 
 
 
 
Figure 4.1.1.5 G Sequence alignment of Spir protein mapping the S456 and S636 
phosphorylation sites.  Sequence alignment of Spir proteins focusing the linker region between the 
WH2 domain and Spir Box, containing the monophosphorylated peptide SF[pS]EHDLAQLR with Ser 
456 residue (Upper panel) and the Spir-FYVE domain with the S636 in monophosphorylated peptide 
FGHIPVYTLGFE[pS]PQR highlighted in red. Both the residues are found to be specific only for 
mammalian Spir-2 proteins. The green asterisk represent the corresponding positions of 
phosphorylated Ser residues. The sequences were aligned by a ClustalW mutiple sequence alignment 
and manually realigned when necessary. Abbreviations : SB, Spir-box; FYVE, FYVE Zn-finger 
domain; S, Serine 
 
 
 LC-MS/MS analysis revealed the presence of S136 only in the JNK-MKK7 induced 
condition where as the other two phosphorylated residues, S456 and S636 were present 
both in the presence and absence of the kinase (Table 2). 
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Table 2. Specificity of JNK-MKK7 on phosphorylation residues 
 
 
 Kinase (JNK-MKK7)                                                       Phosphorylation sites 
                                                                               S136               S456                S636 
1.  − JNK-MKK7                                                      −                        +                          +  
2.  + JNK-MKK7                                                      +                        +                          +  
     
 
4.1.1.6.   Phosphatase treatment abrogated the phosphorylation of Spir-2 
As shown by the aforementioned datas, Spir is phosphorylated and to an extent it 
clarifies that the phosphorylation is induced by JNK-MKK7. In order to further characterize 
the up-shifted band of Spir-2 in the SDS-PAGE, the study employs phosphatase treatment, 
which address the question, whether the electrophoretic mobility shift is by JNK-MKK7 
induced phosphorylation. 
          As an opening wedge, HEK-293 cells were transfected with Spir-2 alone and together 
with JNK-MKK7 as described previously. The cell lysates harvested in IP buffer were 
undergone immunoprecipitation with anti-Myc 9E10 antibody, and incubated with Calf 
Intestinal Alkaline phosphatase (CIAP/CIP, 10U), that catalyzes protein dephosphorylation, 
for 1 hour at 37°C (→ 3.3.8).  
         The resulting samples with and without the treatment with CIP were subjected to 
Western blotting analysis with the same anti-Myc-antibody. Figure 4.1.1.6 shows an obvious 
up-shift of Spir-2 band induced by JNK-MKK7 (Lane 3 and Lane 4) whereas CIP could 
effectively diminish the JNK-induced band shift of Spir-2 (Lane 2). Control experiments were 
performed with the total HEK-293 cell lysates expressing Spir-2, in the presence and 
absence of JNK-MKK7 (Lane 5 and Lane 8) for the clear distinction of intact and 
phosphorylated fragments of Spir proteins. 
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Figure 4.1.1.6  Phosphatase treatment of Spir-2 protein. HEK 293 cells transfected with plasmids 
encoding Spir-2 and JNK-MKK7 alone or together, were subjected to immunoprecipitation using c-Myc 
9E10 antibody. A fraction of the immunoprecipitated sample were treated with calf intestinal alkaline 
phosphatase (CIAP, 10U) for 1hour at 37°C. Expression of Spir-2 protein in both phosphorylated and 
non phosphorylated form were determined by Western blotting using anti-Myc antibody. The 
electrophoretic mobility shift of Spir-2 induced by JNK-MKK7 is abolished by CIP treatment (Lane 2). 
Lane 5 and Lane 8, HEK 293 total cell lysates expressing Spir-2, with and without JNK-MKK7 
respectively; Lane 6 and Lane 7, immunoprecipitate and clear supernatent from c-Myc 
immunoprecipitated Spir-2 protein; Lane 3 and Lane 4, immunoprecipitate and clear supernatent from 
c-Myc immunoprecipitated Spir-2 protein together with JNK-MKK7 . Lane 1, JNK-MKK7 control. 
 
 
4.1.1.7.   Effect of kinase-inactive mutant on Spir-2 phosphorylation 
Inorder to gain insights into the exact phosphorylation characterized by JNK-MKK7, 
the study utilises a kinase-inactive mutant, JNK-MKK7 KD. It is also known as kinase dead 
form of JNK-MKK7 in which the critical lysine residues in the ATP binding sites of JNK (K55A 
and K56A) and MKK7 (K76E) had been replaced by nonphosphorylatable amino acids (Otto 
et al., 2000. 
To analyse the specificity of JNK-MKK7 in the phosphorylation of Spir-2, HEK 293 cells were 
transfected with Spir-2 alone and together with JNK-MKK7 and/or JNK-MKK7 KD. The total 
proteins in the cell lysates were seperated by SDS-PAGE, blotted onto a nitrocellulose 
membrane and detected by immunoblotting using anti-Myc antibody. Figure 4.1.1.7 shows 
that JNK-MKK7-KD did not induce an electrophoretic mobility shift of Spir-2 as JNK-MKK7 
does, which straighten out the finding that phopshorylation is induced by JNK-MKK7. 
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Figure 4.1.1.7.  Characterization of in vitro Spir phosphorylation by JNK-MKK7. HEK 293 cells 
were transfected by with DNA vectors directing the expression of either Spir-2 alone and in 
combination with JNK-MKK7 or a kinase inactive mutant of JNK-MKK7 (JNK-MKK7 KD). 24 hours 
post-transfection, cells were lysed and the expression of total proteins were determined by Western 
blotting using anti-Myc antibody. The phosphorylation of Spir-2 is induced by JNK-MKK7 (Lane 2) 
where as JNK-MKK7 KD did not phosphorylate the protein ( Lane 1). Lane 3 and Lane 4, represents 
the total HEK 293 cell lysates of JNK-MKK7 and Spir-2 as controls. The upshifted band of Spir-2 
representing the phosphorylated fragment is depicted with asterisk (red). 
 
 
Together, these results demonstrated that the electrophoretic mobility shift of Spir-2 
detected in the SDS-PAGE is a result of phosphorylation and the phosphorylation is induced 
by JNK-MKK7. 
 
4.2.   Investigation of the role of Ser136 in the biological activities of Spir 
proteins 
Determining protein phosphorylation sites is often the primodial step in the elucidation 
of a regulation mechanism. Knowledge about the protein phosphorylation sites provides 
description of the biological events following the phosphorylation events. A prerequisite for 
this approach is to mutate potential phosphorylation sites and look for the functional analysis.  
Upon scruitinising the interaction of two prominent actin nucleation factors, Spir and 
formin, a previous study revealed a high affinity Spir binding site at the very C-terminus of 
mammalian formins (FSI sequence) adjecant to it´s core FH2 domain which interact with the 
N-terminal KIND domain of Spir. The FSI sequence was found to be highly conserved only  
with in the Fmn subfamily of formins (Pechlivanis et al., 2009). Recently revealed crystal 
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structure of Spir-KIND/Fmn-2-FSI complex denotes that positively charged residues of Fmn-
FSI peptide is mediating the interaction with acidic residues on the KIND domain (Zeth., et al, 
2011).  
Based on this identification I speculated that the physiological relevance of 
phosphorylation site identified in the Spir-KIND domain, Ser136, may have some effect on 
the interaction with formin proteins. The interesting fact on the other side was that Ser136 
was also conserved in the Spir family of proteins and it fulfills the consensus sequence of 
JNK-MAP kinase as it is immediately succeeded by a proline residue. In order to analyse this 
hypothesis, mutation of Ser136 to both alanine (Ala; A) and glutamic acid (Glu; E) were 
performed. The S136A mutation was used as a non-phosphorylated non-serine control and 
the S136E mutation mimics the phosphorylated state of S136 residue. This may make out 
remarks in the Spir/formin cooperation with a dominant negative and a constitutively active 
forms with Ala and Glu mutants respectively, of the Spir proteins in parallel. 
Before addressing the question of functional relevance of S136 mainly in the 
interaction with formins, experiments were conducted to understand whether JNK-MKK7 is 
inducing phosphorylation of mutants as it does with the wild type and thus provide a 
clarification towards the fact supporting S136 as a JNK-phosphorylation site. 
 
 
4.2.1.   Effect of JNK-MKK7 on the wild type and mutant forms of Spir-2 protein 
 
         Site-directed mutagenesis was done using Stratagene Quickchange Site Directed 
Mutagenesis Kit and the plasmids created were then sequenced through Eurofins MWG 
Operon for confirming the corresponding mutations (Table 3). 
 
Table 3. Primers used for Site directed mutagenesis of S136 in Spir-2-KIND and S150 
in Spir-1-KIND domain.  
 
Mutation name                                                                Primer sequence (5´to 3´)  
S136A                                                   gagagcgaggagcgcgaactcgcccctcagctggagcggctcatc 
S136E                                                   gagagcgaggagcgcgaactcgaacctcagctggagcggctcatc 
S150E                                                  aaggagaatgaagaaagggaattagagcctcccctagagcagcttatc 
 
Introduced sites of mutagenesis are in bold with underline. Mutations were done in Spir-2 
and Spir-1 taking the pcDNA3-Myc-hs-Spir-2 (full length) and pGEX-4T1-NTEV-Spir-1-KIND 
domain as templates. 
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Eukaryotic expression vector pcDNA3 containing Spir-2 wild type (Spir-2,WT), Spir-2, 
Ala mutant (Spir-2, S136A) and Spir-2, Glu mutant (Spir-2, S136E) were transfected to HEK 
293 cell line in the presence and absence of JNK-MKK7 inorder to compare the response of 
wild type and the mutant forms of Spir upon the coexpression with JNK-MKK7. Total cell 
lysates were made at 24 hours post-transfection, were subjected to SDS-PAGE followed by 
Western blot analysis using anti-Spir-2 antibody (4.2.1 A) and the blot was stripped for anti-
Myc-antobody (4.2.1 B) as well.  
 
 
Figure 4.2.1  Effect of JNK-MKK7 on Spir-2 WT/S136A/S136E.  HEK 293 cells were transiently 
transfected with Spir-2/WT, Spir-2/S136A and Spir-2/S136E, both in the presence and absence of 
JNK-MKK7. Proteins were allowed to express after 24 hours of transfection and total cell lysates were 
made 100µl 1X Laemmli buffer and allowed to boil for 5 mints at 90°C. The samples were subjected to 
SDS-PAGE followed by western blotting with a rabbit polyclonal anti-Spir-2 antibody (A). The blot was 
then stripped and reprobed against mouse monoclonal ani-Myc-antibody (B). The blot shows that 
Spir-2 wt is phopshorylated by JNK-MKK7 (Lane 3) but the Ala and Glu mutants not (Lane 2 and Lane 
1). Asterisk indicate the phospho-Spir-2. Total lysates of HEK 293 cells expressing Spir-2, wt, Spir-2, 
S136A and Spir-2, S136E are used as controls (Lane 6, Lane 5 and Lane 4).  
 
The finding implies that that the mutation of the conserved phosphorylated Ser136 
residue in the KIND domain of Spir markedly abandoned the phosphorylation induced by 
JNK-MKK7 which can be easily detected by a comparison from the phosphorylation status of 
Spir-WT (Figure 4.2.1). Lane 3 displays the Spir protein in both non-phosphorylated (lower  
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band) and phosphorylated fragments (upper band). The disappearance of phosphorylated 
fragment is clearly visible in the case of glutamate (Lane 1) and alanine (Lane 2) mutants 
when co-expressed with JNK-MKK7. Lane 6, lane 5 and Lane 4 represents the total HEK 
293 cell lysates expressing Spir-2/WT, Spir-2/S136A and Spir-2/S136E mutants, which are 
used as controls.. The blot of Anti-Spir-2 antibody is stripped and reprobed against anti-Myc-
antibody.  
Concluding, the present finding support the previous results that Spir is 
phosphorylated by JNK and Ser136 is a positive target motif for JNK. 
 
4.2.2.   Mutational analysis of Serine 136 on Spir/formin interaction 
 
4.2.2.1.  GST Pull-down assay to detect the interaction between Spir-2,wt/S136A/S136E 
and Fmn-2  
Further step to investigate the possible role of the phosphorylated S136 residue of 
Spir-2 in the interaction with Fmn-2 were performed with a preliminary GST pull-down assay. 
HEK 293 cells were transiently transfected with Spir-2 WT/S136A/S136E constructs all along 
with JNK-MKK7. After 24 hours of transfection, cell lysates were extracted in pull-down buffer 
and subjected to pull-down assay by incubating with purified GST-Fmn-2-eFSI protein 
coupled to GSH-Sepharose 4B beads. A fraction of the same cell lysates pulled with purified 
GST protein coupled to Sepharose beads in the same manner, were used a control.  The 
pulled fractions were subjected to SDS-PAGE followed by western blot with anti-Myc-
antibody (Figure 4.2.2.1). 
As figured in 4.2.2.1, the interaction of the Spir-KIND-domain and Fmn-2-eFSI is not 
significantly affected by the phosphorylation. In a more precise way, the result points out that 
both the mutant variants of Spir-2, S136A and S136E, interact with the Fmn proteins as the 
wild type does (Lane 3, Lane 6 and Lane 9). Also, it seems to be intersting that 
phosphorylated and non-phosphorylated Spir-2 were pulled out by GST-Fmn-2-eFSI to equal 
amounts in cotransfection approaches with JNK-MKK7, which is highlighted in red circles 
(Lane 1 and Lane 3). This can be led to the hypothesis that both the phosphorylated and 
non-phosphorylated forms of Spir-2 interact with Fmn-2-eFSI with equal affinity, which 
indeed require further investigations to confirm. Nevertheless, one could conclude from the 
observation that phosphorylation does not have a signifant impact on the interaction between 
the mammalian Spir and mammalian Fmn subgroup of formins, since the Ala and Glu 
mutants of Spir-2 interact with Fmn-2, in the same manner the Spir-2 wt does.  
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Figure 4.2.2.1  Interaction of Spir (WT,S136A and S136E) and formin proteins. Purified GST 
protein alone and GST-Fmn-2-eFSI have been coupled to Glutathione-Sepharose beads and 
incubated with HEK293 cell lysates expressing wild type Spir-2/JNK-MKK7, Spir-2, S136A/JNK-MKK7 
and Spir-2,S136E/JNK-MKK7. Myc-tagged proteins expressd in the cell lysates were pulled down 
using GST-Fmn-2-eFSI were detected by immunoblotting with mouse monoclonal anti-Myc antibody. 
Spir protein fragmented equally into phosphorylated and non-phosphorylated forms is shown in the 
red circles (Lane 1 and Lane 3). JNK-MKK7 is visible at a molecular weight of ∼96 KDa. Lane 2, Lane 
5 and Lane 8 shows the pull down of all the three constructs of Spir-2 with GST, as control. Lane 3, 
Lane 6 and Lane 9 are the Spir-2,S136A and Spir-2, S136E pulled form GST-Fmn-2-eFSI. 
 
Eventhough it can not be excluded from the pull down assay that there is no apparent 
difference in the interaction between Spir-2, wild type as well as mutant forms, with 
mammalian formin-2 protein, it is worthwhile to employ a biophysical approach to measure 
the strength of interaction between the proteins. Fluorescence anisotropy measurements 
provide a very sensitive tool to detect and quantify protein interactions (Dr. Markos 
Pechlivanis is acknowledged for the Anisotropy measurements ). 
 
4.2.2.2.  Fluorescence polarization measurement to quantify the Spir/formin 
interaction . 
To monitor the strength of interaction between C-terminal extension of Fmn-2 (Fmn-2-
eFSI) and Spir-KIND domain, flurescent BodipyFL-labeled Fmn-2-eFSI and Spir-1-KIND-WT 
and Spir-1-KIND-S150E were used (Figure 4.2.2.2 A and B) (The phosphorylated S150 in 
human Spir-1 corresponds to the S136 in human Spir-2; the difference exists in the number  
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of aminoacids in both proteins as, Spir-1 protein is with more aminoacid residues (756 amino 
acids) than Spir-2 (728 amino acids). Also, the phosphorylated Ser residue in the KIND 
domain, is highly conserved in both mammalian Spir proteins). From the fluorescence 
anisotropy measurements, the strength of interaction between Spir-1-KIND-WT and Fmn-2-
eFSI as well as Spir-1-KIND-S150E and Fmn-2-eFSI was measured. The values of strength 
measured for the interaction of both the wild type as well as mutant variant of Spir-1 shows 
that, the strength of the Spir-1-KIND WT/Fmn-2-eFSI interaction (Kd~48nM) is almost similar 
to Spir-1-KIND-S150E/Fmn-2-eFSI (Kd~63nM). Thus the anisotropy data along with the pull- 
down assay validate the fact that both the wild type as well as the mutant forms of Spir 
interacts with Fmn-2 protein and also the mutants of Spir restore the similar strength of 
interaction with the the Fmn-2 protein as the wild type does. 
 
 
Figure 4.2.2.2.  Fluorescence anisotropy/polarization measurements probing the interactions of 
Spir-1-KIND-wt and Spir-1-KIND-S150E with Fmn-2-eFSI. Binding of Spir-1-KIND-S150E (A) and 
Spir-1-KIND-wt (B) to BodipyFl-labelled Fmn-2-eFSI (100nM) is shown. The affinities of both the 
constructs of Spir-1-KIND, wt as well as mutant, towards the Fmn-2-eFSI reflects no visible difference, 
as clearly depicted by the dissociation constants. Fmn-2-eFSI protein is marked by the red boxes 
Abbreviations: wt, wild type; ΔP, change in polarization; BodypyFl-labelled  
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4.2.3.  Effect of phosphorylation on autoregulatory interaction of Spir proteins 
 As phosphorylation has no significant impact on the trans-regulatory interaction 
between mammalian Spir and mammalian Fmn proteins, further step to investigate whether 
the identified Ser phosphorylated residue in the KIND domain has been influencing the 
autoregulatory bakfolding property of the Spir proteins, a GST pull-down assay was 
employed. GST fusion proteins, GST-Spir-1-KIND-wt and GST-Spir-1-KIND-S150E, were 
tested for their ability to pull down EGFP-Spir-1-FYVE domain. The purified GST fusion 
proteins were incubated with HEK 293 cell extracts transiently transfected with EGFP-Spir-1-
FYVE, since the interaction is mediated by the FKI (FYVE - KIND interaction sequence) 
residing in the FYVE domain. EGFP-Spir-1-FYVE was detected by immunoblotting using 
anti-EGFP antibody (α-living colors GFP) and horseradish peroxidase conjugated anti-rabbit 
antibody as primary and secondary antibodies respectively, and detected with Enhanced 
Chemiluminescence Kit. The blot shows that the band corresponding to the Spir-1-FYVE 
pulled from the glutamate mutant of Spir-1-KIND is stronger when compared to that pulled 
from the Spir-1-KIND wild type which conveys that glutamate mutant variant of Spir-1-KIND 
is binding more strongly to the Spir-1-FYVE domain when compared to the wild type (Figure 
4.2.3 A and B). In a statistical approach, Spir-1-KIND, S150E mutant possess a 1.4 fold 
stronger interaction than the Spir-1-KIND, wild type towards the Spir-1-FYVE domain (4.2.3 
B). But yet it has to be confirmed by a biophysical approach like fluoresence polarization 
measurement to quantify the strength of interaction between the corresponding N- and C-
terminal domains of Spir.      
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Figure 4.2.3.  Interaction of Spir-KIND WT/S150E and Spir-1-FYVE domain. A. Purified GST 
protein alone and GST-Spir-1-KIND-wt/S150E have been coupled to Glutathione-Sepharose beads 
and incubated with HEK 293 cell lysates expressing EGFP-Spir-1-FYVE. The cell lysates were pulled 
down using GST fusion proteins were detected by immunoblotting with anti-EGFP antibody (α-living 
colors GFP) . Ponceau S staining of the bacterially expressed and purified GST, GST-Spir-1-KIND 
(wt and S150E) and immunoblots of pulled EGFP-Spir-1-FYVE proteins from HEK-293 lysates are 
shown. B. Comparison of the strength of interaction between wt and S150E mutant of Spir-1-KIND 
and the Spir-1-FYVE domain. The intensity if the signal is corrected by the loading control. Mean 
density values are estimated using the Image J programme. Data represents mean ± SD. +P = 0.045 
(Pair sampled T-test). This figure is a representative of two independent experiments. SD, Standard 
deviation; P, probability. 
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5.  Discussion 
 
Spir proteins are the founding members of the emerging group of actin nucleation 
factors with one or multiple WH2 domains as their signature. Since their discovery 
(Wellington et al., 1999; Otto et al., 2000) Spir proteins have seen fruitful investigations which 
unveiled their prominent roles including their interaction with formin proteins (Rosales-Nieves 
A.E, et al., 2006; Quinlan et al., 2007; Pechlivanis M, et al., 2009), followed by the effect of 
this co-operativity in Drosophila and mammalian oogenesis (Dahlgaard K. et al., 2007; 
Pfender, S. et al., 2011). Apart from these interactions, Spir proteins provide an important 
link to understand the role of actin dynamics in regulating the intracellular membrane 
transport through their mambrane localization FYVE domain which makes them to 
specifically target towards the endosomal membrane (Kerkhoff et al., 2001; Morel et al., 
2009). 
The first member identified, among the Spir family of proteins, to be phosphorylated 
was Drosophila p150-Spir and it was shown that the phopshorylation is induced by JNK-
MKK7, a constitutively active form of JNK (Otto et al., 2000). Moreover, it´s role as a direct 
link between JNK and actin organization, unveiled a new proposal for regulatory mechanisms 
among Spir family proteins through signal cascades (Otto et al., 2000). Gaining interest from 
this finding the current work shed light on the phosphorylation status of mammalian Spir 
proteins which have not been described yet.  
The present study concentrate in elucidating the influence of post-translational 
modification on the regulatory events of Spir proteins, which is conducted in two sessions: 
the identification and characterization of phosphorylation sites in the mammalian Spir 
proteins, and later on, role of identified phosphorylation sites in the biological activities of the 
protein.  
 
5.1.   Analysis of phosphorylation of human Spir-2 
 
5.1.1.   Phosphorylation of Spir-2 by JNK-MKK7 
On the basis of the findings observed in p150-Spir protein, phopshorylation studies 
were switched to mammalian homologues. A study regarding the phosphorylation of a 
particular protein carries us through two preliminary stages which is of utter relevance. The 
first attempt was to find out whether the mammalian Spir proteins are phosphorylated or not, 
and secondly, if there is a phosphorylation, are there any kinases involved in catalyzing the 
specific phosphorylation, if yes, the type of the kinase like Ser-Thr kinases or Tyr kinases. 
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Further step will be the identification of phosphorylated residues using the most versatile tool 
to identify the post-translational modifications of the protein, called Mass spectrometry. 
In this study, a phosphorylation profile of human Spir-2 is described for the first time. 
To accomplish this, a pull-down assay with GST-fusion protein, GST-Fmn-2-eFSI was 
conducted. Pull-down experiments with GST-fusion proteins attached to Glutathione beads 
are a screening technique for the identification of protein-protein interaction. The 
phosphorylation studies were conducted in Myc-tagged human Spir-2 protein, with 728 
amino acids. Since the previous study detected phosphorylation of p150-Spir induced by 
JNK-MKK7, we checked the effect of JNK kinase on mammalian Spir. Therefore, Spir-2 in 
presence and absence of JNK-MKK7 was expressed in HEK 293 cells and subsequently cell 
lysates were subjected to pull-down assay using purified GST-Fmn-2-eFSI. The first 
interesting observation was the finding that Spir-2 is phosphorylated by JNK-MKK7 (Figure. 
4.1.1.3 B.). The pulled fragment was clearly visible in two prominent bands, corresponding to 
the molecular weight of phosphorylated and non-phopshorylated residues of Spir-2, in both 
Western blot analysis as well as in Coomassie staining (Figure. 4.1.1.4). The observation 
controlled by Spir-2 protein pulled without JNK-MKK7 give us a hint that it may be a target of 
the kinase, which is further verified using the kinase dead mutant.  
The induction of phosphorylation of Drosophila Spir by JNK-MKK7 was already 
described. JNK-MKK7 is a fusion protein formed by fusing JNK 3 (rat) to it´s upstream 
activator MKK7 (mouse) via a linker region. A previous finding has shown an in vitro 
phosphorylation of aminoterminal c-Jun sequences by JNK-MKK7 which resulted in the 
electrophoretic mobility shift of c-Jun (Otto et al., 2000). MKK7 activates JNK by 
phosphorylating a TPY motif in the central region of JNK.  
In contrast to JNK-MKK7, it´s kinase inactive mutant, JNK-MKK7 KD, which is 
otherwise known as kinase dead mutant, failed to phosphorylate the Spir-2 protein. In JNK-
MKK7 KD, critical lysine residues in the ATP-binding sites of JNK (K55A and K56A) and 
MKK7 (K76E) were replaced by non phosphorylatable amino acids (Otto et al.,2000). 
Supporting the phosphatase data, the migratory and immunoblot behaviour of Spir-2 was 
compared when coexpressed with JNK-MKK7 as well as JNK-MKK7 KD. The results showed 
that, kinase dead mutant did not induce the electrophoretic mobility shift of Spir-2 (Figure 
4.1.1.7). The data indeed proved the role of JNK-MKK7 on Spir phosphorylation. Yet, solely 
taking this data under consideration the prediction of specificity of JNK-MKK7 on Spir-2 
phosphorylation is impossible. One can not exclude the possibility of the existance of another 
kinase in the cascade through which JNK can indirectly phopshorylate the protein. If at all, 
this speculation open a new gateway for future studies which reveals the localization pattern 
as well as the actin organization. Upon stimulation, JNK kinases translocate from the 
cytoplasm to the nucleus where they phosphorylate a variety of transcription factors. In 
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analyzing the subcellular localization of both the intact and dead mutant of JNK-MKK7, it was 
observed that, JNK-MKK7 was found predominantly in the nucleus where as its inactive 
mutant form was totally excluded from the nucleus (Rennefahrt et al., 2002).  Based on these 
findings, it will be interesting to look for the localization pattern of JNK-MKK7 as well as it´s 
mutant form when co-expressed with Spir-2 protein. The analysis can also be performed the 
other way around to look for the localization of Spir together with MAP kinases. Additionally, 
the transient expression of JNK -MKK7 tremendously reduced or led to the complete loss of 
actin stress fibers, whereas the inactive form, JNK-MKK7 KD, had no such effect (Rennefahrt 
et al., 2002). Spir proteins are prominant actin nucleation factors which elicits unbranched 
actin filaments. The above finding thus carry relevance in finding out the changes, if there is 
any, in the actin nucleation ability of Spir proteins together with the active and inactive form 
of the JNK kinase. These expectations are to be revealed by further studies.  
MAP kinases are specifically Ser/Thr kinases and JNK MAP kinases are recruited to 
substrate proteins via docking sites, enabling the kinase to phosphorylate the Ser or Thr 
residues adjecant to prolins (S/TP motifs) (Jacobs, D et al, 1999). Phosphorylation of Spir-2 
has to be further characterized by Mass spectrometric analysis which provide the sequence 
of the phosphorylated peptides as well as the precise site of phosphorylation. But before 
getting into the detailed sequence analysis of the protein we attempted a phosphatase assay 
with Calf Intestinal Alkaline Phosphatase (CIP). 
 
5.1.2.   Dephosphorylation of Spir-2 by alkaline phosphatase 
Inorder to verify that the upshifted band is exactly as a result of phosphorylation, we 
conducted a phosphatase assay using Calf Intestinal Alkaline Phosphatase (CIP). CIP is a 
phosphomonoesterase purified from calf Intestinal mucosa. CIP effectively dephosphorylate 
proteins containing phosphoserine and phosphothreonine, which together account for > 97 % 
of protein bound phosphate in eukaryotic cells (Coligan et al., 1997). Transiently transfected 
HEK 293 cell lines with Spir-2 together with JNK-MKK7 were lysed and immunoprecipitated 
with anti-Myc-antibody and a portion of the immunecomplex was treated with CIP. In Figure. 
4.1.1.6, we found that JNK-MKK7 resulted in the appearance of phosphorylated form of Spir-
2  which got erased by the CIP treatment. This observation confirmed that the upshifted band 
observed is resulted from phosphorylation. The GST pull-down assay together with the 
phosphatase treatment brings the fact that hs-Spir-2 protein as well is phosphorylated by 
JNK-MKK7 like the Drosophila homologue. 
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5.1.3. Determination of novel phosphorylation sites in Spir-2 protein by Mass 
spectrometry 
Incorporation of one or more phosphate groups on specific amino acid side chains 
within a protein, with serine, threonine, tyrosine, and histidine being the most commonly 
studied, often induces significant protein conformational change and consequently profound 
effects on protein activity and protein–protein interactions (Cohen, P., 2002). Since 
phosphorylation is an important regulatory mechanism, we generated a phosphorylation 
mapping with human Spir-2 protein. Phosphorylation sites are identified using contemperory 
mass spectrometrical approach employing nano-HPLC coupled Tandem mass spectrometry. 
Mass spectrometry is ideally suited to the direct identification of protein phosphorylation 
sites. Phosphopeptides present in the mixtures can be sequenced at the femtomole level 
without the need for extensive purification. A great advantage of mass spectrometry is that 
they do not require prior labelling of the target protein with 32P. Regardless of the method 
used to map phosphorylation sites, it is imperative that the native phosphorylation state of 
the target protein be preserved during isolation. 
 The Coomassie staining in the Figure 4.1.1.4 showed the bands corresponding to 
intact and phosphorylated fragments of Spir-2 protein. To read any protein sample derived by 
SDS-PAGE, in mass spectrometer, special preparatory protocols are in need. The process of 
elution of proteins from acrylamide gels are more or less inefficient, so the most 
sraightforward approach to prepare gel-fractionated proteins for MS analysis is the direct 
digestion of protein in the gel (Shevchenko et al., 2007). The fragments corresponding to 
non-phosphorylated and phosphorylated Spir-2 proteins are excised from the gel, digested 
by trypsin to get smaller peptides which were subjected to nano-HPLC-MS/MS analysis.  
MS analysis allowed us to identify a total of three phosphopeptides, with three 
phosphorylated serine residues in each, namely S136, S456 and S636 (Figure 4.1.1.5 
B/C/D). Table.1 shows each confirmed phosphorylation assignment by sequence position 
using QTOF-MS instrument. Out of the three identified phosphorylation sites, S136 takes the 
importance when compared to the two other sites because of three main facts:  
• S136 is located in the N-terminal KIND domain of Spir-2 (Figure 5.1), whose 
role as potential protein interaction module has already unveiled in recent 
studies. 
• S136 is conserved among the Spir family proteins and 
• S136 can be considered as a positive target motif for JNK, since it satisfy the 
consensus sequence of JNK as it is immediately followed by Proline In 
mammals and it has been proved by MS analysis that the site is promisingly 
regulated by JNK-MKK7 (Figure 4.1.1.5 F; Table 2 ). 
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All these particulars of S136 raise the possibility that this site serve a functional guise. 
The second and third phopshorylation residues, S456 and S636, are found to be 
situated in the C-terminus of the protein (Figure 5.1). More precisely, S456 in the linker 
region between the last WH2 domain and Spir-box where as S636 in the membrane binding 
FYVE domain (4.1.1.5 G). Eventhough S456 is outside of known domains, can not be 
considered as an irrelevant site. Both are found as conserved only in mammalian Spir-2 
protein. From the amino acid sequence allignment it is clearly visible that S456 can not be 
considered as a direct target of JNK. In contrast, S636 is succeeded by Proline, in human 
Spir-2 only, and could be a JNK substrate, however it´s phopshorylation was not found to be 
upregulated by JNK-MKK7 in mass spectrometry. Still, the significance of this finding is 
unclear unless put in front for further investigtions. 
 
 
Figure 5.1.  Schematic representation of phosphorylation sites in Spir-2 protein. The structure of 
human Spir-2 with the three newly identified phosphorylation sites, S136, S456 and S636 in defenite 
regions are shown.  
 
A recent study highlighting Spir/formin synergy, presented a crystal structure of Spir-
KIND domain alone and in complex with Fmn-2-FSI peptide with resolution at 2.05A° and 1.8 
A° respectively (Zeth et al., 2011). This finding described the molecular basis of the two 
prominant actin nucleation factors, Spir and formin, that the large interface with conserved 
and positively charged residues of the Fmn-2-FSI peptide electrostatically interact with the 
acidic groove on the surface of KIND domain (Zeth K et al., 2011). In collaboration study with 
Dr. Kornelius Zeth, MPI, Tubingen, we could map the phosphorylated S136 (S136 in Spir-2 
correspond to S150 in Spir-1) in the crystal structure of Spir-KIND domain alone and in 
complex with Fmn-2-FSI peptide. 
The interaction between mammalian Spir and mammalian Fmn subfamily of formins 
was already anatomized, which revealed a new formin Spir interaction (FSI) sequence in the 
very C-terminus of Fmn proteins, which interact with the KIND domain of Spir proteins. 
(Pechlivanis et al, 2009). Since Spir/formin interactions studies are heading in the current 
days, S136 has been selected for further investigation to examine it´s functional relevance. 
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Figure 5.2.  Crystal structure of Spir-1-KIND domain alone and in complex with Fmn-2-FSI 
mapping the S150 phosphorylation site in the KIND domain:  The structure of KIND domain 
shows a dominance of α-helices with very few β-sheets. The S150 residue seems to be accessible in 
the KIND domain alone, but turn towards the inner portion of the structure when complexed with FSI 
peptide which again not accessible to the Fmn-2-FSI. The position of S150 in the structure of Spir-1-
KIND alone and in complex with Fmn-2-FSI peptide is shown in red circles, which is highlighted in the 
boxes.  
 The phopshorylated residue S136 in Spir-2 protein correspond to the S150 residue in Spir-1 protein. The difference in number 
results from the length of the two proteins as hs-Spir-1 is with 756 aminoacids and hs-Spir-2 with 728 aminoacids.  
 
 
5.2.   Functional relevance of phosphorylated Ser136 in Spir-KIND domain 
 To establish that phosphorylation of a given protein plays a crucial role in a process 
under study is the evaluation of the effect of non-phosphorylatable mutations in the candidate 
substrate. Therefore inorder to observe the possible functional role of the phosphorylated 
S136 site in Spir proteins, phosphodeficient and phosphomimic mutants of S136 were 
generated, such as S136A and S136E. The effect of JNK-MKK7 on Spir-2 wildtype (wt) and 
mutant variants were undertook. We found that JNK-MKK7 induces the phosphorylation of 
only the wt type protein and none of the mutants (Figure 4.2.1). This observation make us to 
hypothesise that Spir activity might be regulated by JNK kinases which phosphorylate S136. 
The peptide 134EL[pS]PQLER141 contains mitogen-activated protein kiinase (MAPK) 
phosphorylation site and a SP motif (Proline-directed Ser) which is conserved among Spir 
family proteins. 
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5.2.1.  Influence of phosphorylation on Spir/formin cooperation 
S136 was found in the KIND domain of Spir, which is typically involved in the protein-
protein interactions, which made us to suspect that the phosphorylation site in this domain 
may regulate the ability of Spir to bind to its interaction partners. The prominent interaction 
partner being formins, we examined how the phosphorylation on Spir protein influence the 
transregulatory interaction with the formins. GST pull-down assay to screen the interaction 
followed by fluorescent polarization measurements for quantifying the strength of interaction 
were undertaken. Spir-2 wt, Spir-2, S136A and Spir-2, S136E together with JNK-MKK7 were 
pulled down using GST-Fmn-2-eFSI (Figure 4.2.2.1). The data pointed out two remarkable 
observations, first one being, both the phosphorylated as well as the non-phosphorylated 
fragments of Spir protein was pulled by the formin protein, which indirectly conveys that both 
the fragments are interacting with formin proteins. But it has to be still confirmed and clarified 
that whether both the fragments are interacting with the formins with equal strength or not. 
The second observation was that, mutation on S136 does not affect the interaction with Fmn-
2 protein, which clears that phosphorylation in the KIND domain has no significant impact on  
the interaction between mammalian Spir and mammalian formin proteins.  
  In accordance with this, we quantified the strength of interaction between the Spir-1-
KIND domain and the Fmn-2-eFSI peptide, using both the wild type as well as the 
phosphomimicing mutant, S150E. From the dissociation constants obtained, we could 
conclude the above finding that the wt as well as the mutant form of Spir-KIND interact with 
the Fmn-2-eFSI with similar strength. 
The interaction between mammalian Spir and mammalian formins were previously 
validated already by the pull-down assay and colocalization experiments. The colocalization 
between Fmn-2-eFSI and a membrane targeted Myc-Spir-1-KIND-CAAX were observed in 
Hela cells. Cytoplasmically expressed Fmn-2-eFSI relocated to the plasma membrane along 
with the Spir-1-KIND (Pechlivanis et al., 2009). Obvious visualization studies are in need to 
investigate the difference in localization pattern of Fmn-2-eFSI when co-expressed with Spir-
1-KIND wt and Spir-1-KIND-S150E. 
Like the Fmn subfamily of formins have the FSI domain at the very C-terminus, some 
of the members of formin superfamily contain an autoregulatory peptide in their C-termini 
called Diaphanous autoregulatory domain (DAD) (Giggs H N, 2005). DAD interacts with the 
Diaphanous inhibitory domain (DID) located in the N-termini of the same proteins. This 
intramolecular DID/DAD interaction results in an autoinhibited conformation of  the formin 
proteins. This inhibited confirmation must be released by the Rho small G- protein for the 
acivation of formin proteins (Li and Giggs, 2005; Otomo et al., 2005). Homologous DAD/DID 
sequences could not be found in the Fmn subfamily members (Pechlivanis et al., 2009). This 
conveys that the Fmn subfamily of formins may not be potentially regulated by an 
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autoinhibitory backfolding interactions but can be through a transregulatory interaction with 
Spir-KIND domain utilising their FSI module. More studies have to be added to understand 
the effect of kinase mediated phopshorylation on the Spir/formin complex.   
 
5.2.2.   Phosphorylation on autoregulatory backfolding of Spir 
Apart from the intermolecular interaction with Fmn subgroup of formins, we also 
performed experiments to look for the effect of phosphorylation on the autoregulatory 
interaction of Spir protein which is mediated by the N-terminal KIND and C-terminal FYVE 
domain. The specific sequence mediating this binding is FYVE/KIND interaction sequence 
(FKI) located in the FYVE domain (Tittel, Dietrich, Pechlivanis, Samol, Pleiser, Schwille and 
Kerkhoff., manuscript in preparation). We conducted the experiment in which EGFP tagged 
Spir-1-FYVE was pulled from the purified GST-tagged Spir-1-KIND wt and th Spir-1-KIND 
S150E. The data figured in 4.2.3, shows that Spir-1-KIND S150E possess more intensive 
binding with the Spir-FYVE domain rather than the wt. Even though, the finding must be 
validated through a quantitative assay like flurescence anisotropy, the data shows that 
phosphomimicing mutant of Spir interact more strongly to the membrane binding FYVE 
domain. It raises a possibility that autoinhibition of Spir proteins through backfolding is 
regulated by phosphorylation. This finding must be validated by a biophysical approach 
which enable the quantification of the strength of FYVE/KIND interaction  
FYVE domains are important zinc finger domains which recruite a subset of proteins 
to the endosomal membrane by binding to phosphatidylinositol-3-phosphate (PI(3)P) 
(Stenmark, 2005). Spir consists of a modified FYVE domain, lacking the basic cluster 
between cysteines 2 and 3, mediating the PI(3)P binding and having a loop insertion 
between cysteines 6 and 7. Fyve domain form a ´turret loop´ to penetrate the membrane. 
Membrane binding property of the Spir proteins depends on the integrity of Spir-box and 
FYVE domain (Kerkhoff et al., 2001). If the above finding clarifies the intensive binding if the 
mutant when compared to the wild type form of Spir, which is to be studied in detail, then we 
could hypothesise that the phopshorylation alters the membrane localization of Spir. More 
precisely, when the KIND domain interact with the FYVE domain more strongly, it will result 
in pulling the FYVE from the intracellular membranes making the domain more accessible for 
binding with the KIND domain. It remains to be determined in future studies. 
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6.  Conclusion and perspectives 
 
The identification of sites of post-translational modification is crucial for fully 
deciphering the biological roles of any given protein. The study has demonstrated the power 
of combining biochemical and mass spectrometrical analysis in precise identification of 
phosphoresidues and provides an essential foundation in elucidating the biological events 
following phosphorylation.  
The current study generated a phosphorylation profile of mammalian Spir protein 
using nano-LC-MS/MS analysis, which revealed three new serine phosphorylation residues, 
in human Spir-2 protein. One among the three phosphorylated serine residue, S136, residing 
in the N-terminal KIND domain, a protein interaction module, was conserved in both 
mammalian Spir proteins, Spir-1 and Spir-2, Drosophila p150-Spir and Spir Ciona savignyi 
(Pem-5). Apart from the fact that the sequence following S136 satisfy the JNK consensus 
sequence (ST/P motif), mass spectrometrical approaches could ascertain that this site could 
be assigned as a positive target motif for JNK,. The other two sites, S456 and S636, residing 
in the C-terminus of the Spir-2 protein was not found to be conserved among the Spir family 
of proteins. Since KIND domain is a potential protein interaction module, inorder to gain 
insights into the functional relevance of conserved S136 in the N-terminal KIND domain, 
mutational analysis was performed. Emerging data indicated that phosphorylation has no 
significant impact on the interaction between Spir and formin proteins. Moreover, the mutants 
restore the similar strength of interaction as the wild type does. Further verification in 
understanding the influence of phosphorylation on the autoregulatory interaction between N-
terminal N-terminal KIND and C-terminal FYVE domains of Spir proteins revealed that the 
glutamate mutant possess a strong binding affinity towards Spir-FYVE in contrast to the wt, 
which has to be verified by a biophysical approach like fluorescence anisotropy 
measurements. 
Further research should focus on the studies incorporating localization patterns of 
Spir proteins under, both phosphorylated and non-phosphorylated conditions. 
Immunostaining followed by Fluorescence microscopy will shed light to get an idea whether 
phosphorylation inhibit or augment the membrane targeting property of the protein. It also 
carries interest to look for the alterations in the localization of Spir protein under serum 
starvation, if at all, examining the capability of Spir proteins to induce actin filaments under 
serum deprived conditions will open efficacious avenues for future studies. 
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APPENDIX 
 
Appendix -I- Abbreviations and acronyms 
 
APS    Ammonium persulfate 
Arp2/3    actin-related protein 2 and 3 
ADP    adenosin diphosphate 
ATP    adenosin triphosphate 
bp    base pairs 
BSA    Bovine serum albumin 
Cc    Critical concentration 
Capu    Cappuccino 
cDNA    complementary DNA 
Co-IP    co-immunoprecipitation 
Cobl    Cordon-bleu 
Cdc42    Cell division cycle 42 
CE    capillary electrophoresis 
CID    Collision-induced dissociation 
DAAM    dishevelled-associated activator of morphogenesis 
DAD    diaphanous autoregulatory domain 
Dia    diaphanous 
DID    diaphanous inhibitory domain 
DMEM    Dulbecco's modified Eagle's medium 
DMSO    Dimethyl Sulfoxide 
DNA    Deoxyribonucleic acid 
dSpir    Drosophila Spir 
eGFP    enhanced green fluorescent protein 
E. coli    Escherichia coli 
ECL    enhanced chemiluminescent light detection 
EDTA    Ethylenediaminetetraacetic acid 
EEA1    early endosome antigen 1 
ERK-1    extracellular-signal-regulated kinase 1 
ESI     Electrospray ionisation 
FYVE    Fab1p, YOTB, Vac1p, EEA1 
FH1    formin homology 1 
 
                                                                                  Appendix -I- Abbreviations and acronyms 
 
 
75 
 
FH2    formin homology 2 
FHOD     formin homology domain-containing protein 
FRL    formin-related gene in leukocytes 
FSI    formin-Spir Interaction site 
FKI    FYVE-KIND Interaction site 
Fmn    formin 
F-actin    filamentous actin 
FCS    fetal calf serum 
G proteins    guanine nucleotide-binding proteins 
G-actin    globular actin 
GDF     GDI-displacement factor 
GDI     GDP-dissociation inhibitor 
GDP     Guanosine diphosphate 
Glu     Glutamic acid 
GST     glutathione S-transferase 
GTP     Guanosine-5'-triphosphate 
GC     Gas chromatography 
HEK 293    human embryonic kidney 293 cells 
His     Histidine 
HRP     horseradish peroxidase 
HPLC     High-performance liquid chromatography 
IgG     Immunoglobulin G 
IP     Immunoprecipitation 
IPTG     Isopropyl beta-D-1-thiogalactopyranoside 
JMY     junction-mediating regulatory protein 
JNK     c-Jun N-terminal kinase 
kb     kilo bases 
kDa     kilo Dalton 
kV     Kilovolt 
KIND    kinase non-catalytic C-lobe domain 
L-3     linker region 3 
LB     Luria Bertani 
Lmod-2    Leiomodin-2 
mA     milliampere 
mAbp1    mammalian actin-binding protein 1 
MCS     multiple cloning site 
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ml     milliliter 
mM     millimolar 
µM     micromolar 
M     molar 
MWCO    molecular-weight cutoff 
MreB     Murein formation cluster E B 
MAPKKK    Mitogen activated protein kinase –kinase-kinase 
MAPKK    Mitogen activated protein kinase –kinase 
MAPK     Mitogen-activated protein kinase 
m/z     mass to charge ratio 
MS     Mass spectrometer/Mass spectrometry 
MS/MS    Tandem mass spectrometry 
MALDI    Matrix-assisted laser desorption/ionisation  
NPF     nucleation promoting factor 
OD     Optical density 
Par M     Partitioning M 
PA     phosphatidic acid 
PAGE     Polyacrylamide gel electrophoresis 
PBS     phosphate buffered saline 
PCR     polymerase chain reaction 
Pen     Penicillin 
PEM-5    Posterior end mark-5 
PTM     Post-translational modification 
pSer    phosphorylated Ser 
pThr    phosphorylated Thr 
pTyr    phosphorylated Tyr 
Pfu     Pyrococcus furiosus 
Q-TOF    Quadrapole-Time-of-flight 
rpm     rounds per minute 
RPLC     Reversed phase liquid chromatography  
SCAR     suppressor of cAMP receptor 
SDS     Sodium dodecyl sulfate 
Strep     Streptomycin 
SB     Spir-Box 
Ser     serine 
s    seconds 
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TARP     translocated actin recruiting phosphoprotein 
TEMED    Tetramethylethylenediamine 
TGN     trans-Golgi network 
Thr     Threonine 
Tyr     Tyrosine 
tRNA     transfer RNA 
VSV-G    Vesicular stomatitis virus glycoprotein 
WASP    Wiskott-Aldrich syndrome protein 
WH2     WASP homology domain 2 
WAVE    WASp family verprolin homologous protein 
WASH    WASP and SCAR homologue 
WB     Western Blot 
WHAMM  Wiskott Aldrich syndrome protein homologue associated with 
actin, golgi membranes and microtubules 
WHIF1    WH2 domain-containing formin 1 
 wt     wild type 
 ºC     degree Celsius 
  α    Alpha 
  β    Beta 
  γ    Gamma 
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Appendix -II- Human Spir-2 sequence  
                                                (NCBI Accession: CAD19439.1) 
 
  atg gac gcg ggt cgg cgc gcg gga ggc gat gac ggc ccc gcc atg gcc cgg gcg ggc agc  < 60 
  M   D   A   G   R   R   A   G   G   D   D   G   P   A   M   A   R   A   G   S    < 20 
 
  tgc ggc ggc gcc gcg gca ggc gca ggg cgg ccg gag ccc tgg gag ctg tcc ctg gag gag  < 120 
  C   G   G   A   A   A   G   A   G   R   P   E   P   W   E   L   S   L   E   E    < 40 
 
  gtg ctg aag gcc tac gag cag ccg ctc aac gag gag cag gcg ttg gcc gtg tgc ttc cag  < 180 
  V   L   K   A   Y   E   Q   P   L   N   E   E   Q   A   L   A   V   C   F   Q    < 60 
 
  ggc tgc cgc ggg ctg cgg ggc tcg ccg ggc cgg cgc ctg cgg gat acc ggg gac ctc ctg  < 240 
  G   C   R   G   L   R   G   S   P   G   R   R   L   R   D   T   G   D   L   L    < 80 
 
  ctg cgc ggg gac ggc tcg gtc ggg gcg cgg gag ccc gag gcc gcg gaa cct gca acc atg  < 300 
  L   R   G   D   G   S   V   G   A   R   E   P   E   A   A   E   P   A   T   M    < 100 
 
  gtc gtg cca cta gcc agc tcg gaa gcc cag acc gtg cag tcc ctc ggc ttc gcc atc tac  < 360 
  V   V   P   L   A   S   S   E   A   Q   T   V   Q   S   L   G   F   A   I   Y    < 120 
 
  cgc gcg ctg gac tgg ggg ctg gac gag agc gag gag cgc gaa ctc agc cct cag ctg gag  < 420 
  R   A   L   D   W   G   L   D   E   S   E   E   R   E   L   S   P   Q   L   E    < 140 
 
  cgg ctc atc gac ctc atg gcc aac aac gac agc gag gac agc ggc tgc ggt gcc gcc gat  < 480 
  R   L   I   D   L   M   A   N   N   D   S   E   D   S   G   C   G   A   A   D    < 160 
 
  gag ggc tac ggg ggt ccc gag gag gag gag gag gcc gag ggc gta ccc cgc agc gtg cgc  < 540 
  E   G   Y   G   G   P   E   E   E   E   E   A   E   G   V   P   R   S   V   R    < 180 
 
  acc ttt gcc cag gcc atg cgg ctg tgc gcg gcg cgg ctg acc gac ccc cgg ggc gca cag  < 600 
  T   F   A   Q   A   M   R   L   C   A   A   R   L   T   D   P   R   G   A   Q    < 200 
 
  gcg cat tac cag gcc gtg tgc cgc gcg ctc ttc gtg gag acg ctg gag ctg cgg gcc ttc  < 660 
  A   H   Y   Q   A   V   C   R   A   L   F   V   E   T   L   E   L   R   A   F    < 220 
 
  ctg gcc agg gtc cgg gag gcc aag gag atg ctg cag aag ctt cgg gag gac gag ccg cat  < 720 
  L   A   R   V   R   E   A   K   E   M   L   Q   K   L   R   E   D   E   P   H    < 240 
 
  ctg gag acg cct cgg gca gag ctg gac agc ctg ggt cac aca gac tgg gcc cga ctg tgg  < 780 
  L   E   T   P   R   A   E   L   D   S   L   G   H   T   D   W   A   R   L   W    < 260 
 
  gtt cag ctc atg cgg gag ctc cgc cgc gga gtg aag ctg aag aag gtg caa gag cag gag  < 840 
  V   Q   L   M   R   E   L   R   R   G   V   K   L   K   K   V   Q   E   Q   E    < 280 
 
  ttc aac ccc ctc ccc acc gag ttc cag ctc acg ccc ttc gag atg ctg atg cag gac atc  < 900 
  F   N   P   L   P   T   E   F   Q   L   T   P   F   E   M   L   M   Q   D   I    < 300 
   
  cgg gcc cgg aac tac aag ctg cgc aag gtc atg gtg gat ggg gac atc ccg ccc cgg gtg  < 960 
  R   A   R   N   Y   K   L   R   K   V   M   V   D   G   D   I   P   P   R   V    < 320 
 
  aag aag gac gct cac gag ctc atc ctg gac ttt atc cgc tca cgg cct cca ctg aag cag  < 1020 
  K   K   D   A   H   E   L   I   L   D   F   I   R   S   R   P   P   L   K   Q    < 340 
 
  gtc tct gag agg cgg ctg cgc ccg ttg cca cca aag caa agg tcc ctg cat gag aag atc  < 1080 
  V   S   E   R   R   L   R   P   L   P   P   K   Q   R   S   L   H   E   K   I    < 360 
 
  ctg gag gag atc aag cag gag cgg agg ctg cgc ccg gtg cgg ggc gag ggc tgg gct gcc  < 1140 
  L   E   E   I   K   Q   E   R   R   L   R   P   V   R   G   E   G   W   A   A    < 380 
 
  cgc ggg ttt ggc tct ctg ccc tgc atc ctc aac gcc tgc tcc gga gat gcc aag tcc acc  < 1200 
  R   G   F   G   S   L   P   C   I   L   N   A   C   S   G   D   A   K   S   T    < 400 
 
  tcc tgc atc aac ctg tca gtc aca gat gct ggg ggc agc gcc cag cgc ccg cgg ccc cgc  < 1260 
  S   C   I   N   L   S   V   T   D   A   G   G   S   A   Q   R   P   R   P   R    < 420 
 
  gtg ctg ctc aag gcg cct acc ttg gct gaa atg gaa gag atg aat aca tct gag gaa gaa  < 1320 
  V   L   L   K   A   P   T   L   A   E   M   E   E   M   N   T   S   E   E   E    < 440 
 
   
 gag tct ccg tgt ggg gag gtg acg ctg aaa cgg gac cgc tcc ttc tca gag cat gac ctg  < 1380 
  E   S   P   C   G   E   V   T   L   K   R   D   R   S   F   S   E   H   D   L    < 460 
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gcc cag ctc cga agt gag gtg gcc tct ggc ctg cag tcg gcc acc cac ccc cca gga ggg  < 1440 
  A   Q   L   R   S   E   V   A   S   G   L   Q   S   A   T   H   P   P   G   G    < 480 
 
  acg gag cca cca cgg ccc cga gct ggc agt gcg cat gtg tgg agg ccc ggc tcc cga gac  < 1500 
  T   E   P   P   R   P   R   A   G   S   A   H   V   W   R   P   G   S   R   D    < 500 
 
  cag ggt acc tgt ccc gcg agt gtc tct gac ccc agc cac ccc cta ctc agc aac cgg ggc  < 1560 
  Q   G   T   C   P   A   S   V   S   D   P   S   H   P   L   L   S   N   R   G    < 520 
 
  tcc tcg ggg gac aga ccc gag gcc tcc atg acc ccc gat gcc aaa cac ctg tgg ctg gag  < 1620 
  S   S   G   D   R   P   E   A   S   M   T   P   D   A   K   H   L   W   L   E    < 540 
 
  ttc agc cac ccc gtg gag agc ctg gcg ctg act gtg gaa gag gtg atg gac gtg cgc cgt  < 1680 
  F   S   H   P   V   E   S   L   A   L   T   V   E   E   V   M   D   V   R   R    < 560 
 
  gtg ctg gtg aag gcc gag atg gaa aag ttt ttg cag aac aag gag ctc ttc agc agt ctg  < 1740 
  V   L   V   K   A   E   M   E   K   F   L   Q   N   K   E   L   F   S   S   L    < 580 
 
  aag aag ggg aag att tgc tgc tgc tgc cgg gcc aag ttc ccg ctg ttc tcg tgg ccg ccc  < 1800 
  K   K   G   K   I   C   C   C   C   R   A   K   F   P   L   F   S   W   P   P    < 600 
 
  agc tgt ctc ttc tgc aag aga gcc gtc tgc act tcc tgt agc ata aag atg aag atg cct  < 1860 
  S   C   L   F   C   K   R   A   V   C   T   S   C   S   I   K   M   K   M   P    < 620 
   
  tct aag aaa ttt gga cac atc cct gtc tac aca ctg ggc ttt gag agt cct cag agg gta  < 1920 
  S   K   K   F   G   H   I   P   V   Y   T   L   G   F   E   S   P   Q   R   V    < 640 
   
  tca gct gcc aaa acc gcg cca atc cag aga aga gac atc ttt cag tct ctg caa ggg cca  < 1980 
  S   A   A   K   T   A   P   I   Q   R   R   D   I   F   Q   S   L   Q   G   P    < 660 
 
  cag tgg cag agc gtg gag gag gcg ttc ccc cac atc tac tcc cac ggc tgt gtc ctg aag  < 2040 
  Q   W   Q   S   V   E   E   A   F   P   H   I   Y   S   H   G   C   V   L   K    < 680 
 
  gat gtc tgc agt gag tgc acc agc ttt gtg gca gac gtg gtg cgt tcc agc cgc aag agc  < 2100 
  D   V   C   S   E   C   T   S   F   V   A   D   V   V   R   S   S   R   K   S    < 700 
 
  gtg gac gtc ctc aac act acg cca cga cgc agt cgc cag acc caa tcc ctc tac atc cct  < 2160 
  V   D   V   L   N   T   T   P   R   R   S   R   Q   T   Q   S   L   Y   I   P    < 720 
 
  aac acc agg act ctt gac ttc aag tga  < 2187 
  N   T   R   T   L   D   F   K   *    < 728 
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Appendix -III- Construct overview 
 
Construct Description Restriction sites Purpose 
pcDNA3-Myc- 
hs-Spir-2 
Myc-Spir-2 f.l  
(full length)  
BamHI / HindIII 
GST pull-down,  
Mass spectrometry, 
Immunoprecipitation. 
pGEX- 4T1- NTEV-
mFmn-2-eFSI 
GST-Fmn-2-eFSI EcoRI / SalI 
GST pull-down; 
 Anisotropy 
pcDNA3-Myc-JNK-
MKK7 
Myc-JNK-MKK7 BamHI / XbaI 
GST pull-down, 
Immunoprecipitation 
pcDNA3-Myc- 
hs-Spir-2-S136A 
Myc-Spir-2-S136A BamHI / HindIII 
Mutation analysis; 
GST pull-down 
pcDNA3-Myc- 
hs-Spir-2-S136E 
Myc-Spir-2-S136E BamHI / HindIII 
Mutation analysis;  
GST pull-down 
pGEX- 4T1- NTEV-
hs-Spir-1-KIND 
GST-Spir-1-KIND BamHI / XhoI GST pull-down 
pGEX- 4T1- NTEV-
hs-Spir-1-KIND-
S150E 
GST-Spir-1-KIND-
S150E 
BamHI / XhoI GST pull-down 
pEGFP-C1-hs-Spir-1-
FYVE 
EGFP-Spir-1-FYVE XhoI / BamHI GST pull-down 
pProExHtb-hs-Spir-1-
KIND 
His-Spir-1-KIND BamHI / XhoI Anisotropy 
pProExHtb-hs-Spir-1-
KIND-S150E 
His-Spir-1-KIND-
S150E 
BamHI / XhoI Anisotropy 
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